18443281	11421	Jayasooriya AP	Mice lacking angiotensin-converting enzyme have increased energy expenditure, with reduced fat mass and improved glucose clearance.	Proceedings of the National Academy of Sciences of the United States of America	2008	56
23619363	11421	Gonzalez-Villalobos RA	The absence of intrarenal ACE protects against hypertension.	The Journal of clinical investigation	2013	59
24933400	11421	Bostick B	Dipeptidyl peptidase inhibition prevents diastolic dysfunction and reduces myocardial fibrosis in a mouse model of Western diet induced obesity.	Metabolism	2014	22
11172066	11450	Fruebis J	Proteolytic cleavage product of 30-kDa adipocyte complement-related protein increases fatty acid oxidation in muscle and causes weight loss in mice.	Proceedings of the National Academy of Sciences of the United States of America	2001	277
11522676	11450	Maeda N	PPARgamma ligands increase expression and plasma concentrations of adiponectin, an adipose-derived protein.	Diabetes	2001	227
11861525	11450	Combs TP	Induction of adipocyte complement-related protein of 30 kilodaltons by PPARgamma agonists: a potential mechanism of insulin sensitization.	Endocrinology	2002	94
12068289	11450	Maeda N	Diet-induced insulin resistance in mice lacking adiponectin/ACRP30.	Nature medicine	2002	365
12196466	11450	Nishizawa H	Androgens decrease plasma adiponectin, an insulin-sensitizing adipocyte-derived protein.	Diabetes	2002	95
12451000	11450	Okamoto Y	Adiponectin reduces atherosclerosis in apolipoprotein E-deficient mice.	Circulation	2002	156
12496257	11450	Pajvani UB	Structure-function studies of the adipocyte-secreted hormone Acrp30/adiponectin. Implications fpr metabolic regulation and bioactivity.	The Journal of biological chemistry	2003	203
12540596	11450	Combs TP	Sexual differentiation, pregnancy, calorie restriction, and aging affect the adipocyte-specific secretory protein adiponectin.	Diabetes	2003	84
12578865	11450	Ouchi N	Reciprocal association of C-reactive protein with adiponectin in blood stream and adipose tissue.	Circulation	2003	137
14624132	11450	Ouchi N	Obesity, adiponectin and vascular inflammatory disease.	Current opinion in lipidology	2003	135
14724832	11450	Kamada Y	Enhanced carbon tetrachloride-induced liver fibrosis in mice lacking adiponectin.	Gastroenterology	2003	79
15210937	11450	Hug C	T-cadherin is a receptor for hexameric and high-molecular-weight forms of Acrp30/adiponectin.	Proceedings of the National Academy of Sciences of the United States of America	2004	185
16374858	11450	Schattenberg JM	JNK1 but not JNK2 promotes the development of steatohepatitis in mice.	Hepatology	2006	109
16374859	11450	Ding X	Exendin-4, a glucagon-like protein-1 (GLP-1) receptor agonist, reverses hepatic steatosis in ob/ob mice.	Hepatology	2006	87
16567517	11450	Zvonic S	Characterization of peripheral circadian clocks in adipose tissues.	Diabetes	2006	131
16890763	11450	Shore SA	Adiponectin attenuates allergen-induced airway inflammation and hyperresponsiveness in mice.	The Journal of allergy and clinical immunology	2006	78
17476695	11450	Yamaguchi K	Inhibiting triglyceride synthesis improves hepatic steatosis but exacerbates liver damage and fibrosis in obese mice with nonalcoholic steatohepatitis.	Hepatology	2007	180
17569885	11450	Itoh M	Increased adiponectin secretion by highly purified eicosapentaenoic acid in rodent models of obesity and human obese subjects.	Arteriosclerosis, thrombosis, and vascular biology	2007	59
17717599	11450	Kim JY	Obesity-associated improvements in metabolic profile through expansion of adipose tissue.	The Journal of clinical investigation	2007	371
18158361	11450	Nishimura M	Adiponectin prevents cerebral ischemic injury through endothelial nitric oxide synthase dependent mechanisms.	Circulation	2008	51
18239070	11450	Sauter NS	The antiinflammatory cytokine interleukin-1 receptor antagonist protects from high-fat diet-induced hyperglycemia.	Endocrinology	2008	58
18326786	11450	Membrez M	Gut microbiota modulation with norfloxacin and ampicillin enhances glucose tolerance in mice.	FASEB journal 	2008	104
18375438	11450	Li M	Treatment of obese diabetic mice with a heme oxygenase inducer reduces visceral and subcutaneous adiposity, increases adiponectin levels, and improves insulin sensitivity and glucose tolerance.	Diabetes	2008	103
18426778	11450	Peterson SJ	L-4F treatment reduces adiposity, increases adiponectin levels, and improves insulin sensitivity in obese mice.	Journal of lipid research	2008	69
18682512	11450	Aguilar-Salinas CA	High adiponectin concentrations are associated with the metabolically healthy obese phenotype.	The Journal of clinical endocrinology and metabolism	2008	54
18827021	11450	Jones HN	High-fat diet before and during pregnancy causes marked up-regulation of placental nutrient transport and fetal overgrowth in C57/BL6 mice.	FASEB journal 	2009	67
19447867	11450	Landskroner-Eiger S	Proangiogenic contribution of adiponectin toward mammary tumor growth in vivo.	Clinical cancer research 	2009	54
19461119	11450	Basseri S	The chemical chaperone 4-phenylbutyrate inhibits adipogenesis by modulating the unfolded protein response.	Journal of lipid research	2009	60
20064576	11450	Cho AS	Chlorogenic acid exhibits anti-obesity property and improves lipid metabolism in high-fat diet-induced-obese mice.	Food and chemical toxicology 	2010	53
20065609	11450	Libby P	Inflammation in atherosclerosis: transition from theory to practice.	Circulation journal 	2010	140
20604941	11450	Griffin TM	Diet-induced obesity differentially regulates behavioral, biomechanical, and molecular risk factors for osteoarthritis in mice.	Arthritis research and therapy	2010	48
20858684	11450	Duval C	Adipose tissue dysfunction signals progression of hepatic steatosis towards nonalcoholic steatohepatitis in C57BL/6 mice.	Diabetes	2010	51
21256905	11450	Xu J	Synergistic steatohepatitis by moderate obesity and alcohol in mice despite increased adiponectin and p-AMPK.	Journal of hepatology	2011	45
21462320	11450	Kobori M	Chronic dietary intake of quercetin alleviates hepatic fat accumulation associated with consumption of a Western-style diet in C57/BL6J mice.	Molecular nutrition and food research	2011	41
21737828	11450	Reinke C	Effects of different acute hypoxic regimens on tissue oxygen profiles and metabolic outcomes.	Journal of applied physiology	2011	50
21953366	11450	Griffin TM	Induction of osteoarthritis and metabolic inflammation by a very high-fat diet in mice: effects of short-term exercise.	Arthritis and rheumatism	2012	36
22156343	11450	Konter JM	Adiponectin attenuates lipopolysaccharide-induced acute lung injury through suppression of endothelial cell activation.	Journal of immunology	2012	32
22388319	11450	Qin F	The polyphenols resveratrol and S17834 prevent the structural and functional sequelae of diet-induced metabolic heart disease in mice.	Circulation	2012	36
22457829	11450	Lam YY	Increased gut permeability and microbiota change associate with mesenteric fat inflammation and metabolic dysfunction in diet-induced obese mice.	PloS one	2012	74
23236485	11450	Ables GP	Methionine-restricted C57BL/6J mice are resistant to diet-induced obesity and insulin resistance but have low bone density.	PloS one	2012	31
23524376	11450	Guo R	Adiponectin knockout accentuates high fat diet-induced obesity and cardiac dysfunction: role of autophagy.	Biochimica et biophysica acta	2013	31
23562077	11450	Mansuy-Aubert V	Imbalance between neutrophil elastase and its inhibitor Î±1-antitrypsin in obesity alters insulin sensitivity, inflammation, and energy expenditure.	Cell metabolism	2013	31
24998914	11450	Cawthorn WP	Bone marrow adipose tissue is an endocrine organ that contributes to increased circulating adiponectin during caloric restriction.	Cell metabolism	2014	64
26417088	11450	Aye IL	Adiponectin supplementation in pregnant mice prevents the adverse effects of maternal obesity on placental function and fetal growth.	Proceedings of the National Academy of Sciences of the United States of America	2015	15
10449410	11545	Oliver FJ	Resistance to endotoxic shock as a consequence of defective NF-kappaB activation in poly (ADP-ribose) polymerase-1 deficient mice.	The EMBO journal	1999	120
14709739	11545	Calabrese CR	Anticancer chemosensitization and radiosensitization by the novel poly(ADP-ribose) polymerase-1 inhibitor AG14361.	Journal of the National Cancer Institute	2004	101
19684606	11545	Farez MF	Toll-like receptor 2 and poly(ADP-ribose) polymerase 1 promote central nervous system neuroinflammation in progressive EAE.	Nature immunology	2009	53
19969072	11545	Mukhopadhyay P	Cannabinoid-2 receptor limits inflammation, oxidative/nitrosative stress, and cell death in nephropathy.	Free radical biology and medicine	2010	52
20590569	11545	Mukhopadhyay P	CB1 cannabinoid receptors promote oxidative/nitrosative stress, inflammation and cell death in a murine nephropathy model.	British journal of pharmacology	2010	41
24016618	11545	Skor MN	Glucocorticoid receptor antagonism as a novel therapy for triple-negative breast cancer.	Clinical cancer research 	2013	33
24854277	11545	Ying Y	Targeted deletion of p53 in the proximal tubule prevents ischemic renal injury.	Journal of the American Society of Nephrology 	2014	20
16388309	11576	Bakker J	Alpha-fetoprotein protects the developing female mouse brain from masculinization and defeminization by estrogens.	Nature neuroscience	2006	70
17086172	11576	Gouon-Evans V	BMP-4 is required for hepatic specification of mouse embryonic stem cell-derived definitive endoderm.	Nature biotechnology	2006	115
10082470	11596	Schmidt AM	Activation of receptor for advanced glycation end products: a mechanism for chronic vascular dysfunction in diabetic vasculopathy and atherosclerosis.	Circulation research	1999	113
11108954	11596	Schmidt AM	The biology of the receptor for advanced glycation end products and its ligands.	Biochimica et biophysica acta	2000	138
19005067	11596	Muhammad S	The HMGB1 receptor RAGE mediates ischemic brain damage.	The Journal of neuroscience 	2008	87
19218854	11596	van Zoelen MA	Role of toll-like receptors 2 and 4, and the receptor for advanced glycation end products in high-mobility group box 1-induced inflammation in vivo.	Shock	2009	84
21270403	11596	Yamamoto Y	Septic shock is associated with receptor for advanced glycation end products ligation of LPS.	Journal of immunology	2011	37
24453429	11596	Schiopu A	S100A8 and S100A9: DAMPs at the crossroads between innate immunity, traditional risk factors, and cardiovascular disease.	Mediators of inflammation	2013	29
11606482	11606	MassiÃ©ra F	Adipose angiotensinogen is involved in adipose tissue growth and blood pressure regulation.	FASEB journal 	2001	89
15118095	11606	Paterson JM	Metabolic syndrome without obesity: Hepatic overexpression of 11beta-hydroxysteroid dehydrogenase type 1 in transgenic mice.	Proceedings of the National Academy of Sciences of the United States of America	2004	81
18025412	11606	Santos SH	Mas deficiency in FVB/N mice produces marked changes in lipid and glycemic metabolism.	Diabetes	2008	52
19948988	11606	Wysocki J	Targeting the degradation of angiotensin II with recombinant angiotensin-converting enzyme 2: prevention of angiotensin II-dependent hypertension.	Hypertension	2010	43
20088827	11606	Daugherty A	Angiotensin II infusion promotes ascending aortic aneurysms: attenuation by CCR2 deficiency in apoE-/- mice.	Clinical science	2010	56
20305660	11606	Rudolph V	Myeloperoxidase acts as a profibrotic mediator of atrial fibrillation.	Nature medicine	2010	54
20921429	11606	Brands MW	Interleukin 6 knockout prevents angiotensin II hypertension: role of renal vasoconstriction and janus kinase 2/signal transducer and activator of transcription 3 activation.	Hypertension	2010	43
22493070	11606	Briones AM	Adipocytes produce aldosterone through calcineurin-dependent signaling pathways: implications in diabetes mellitus-associated obesity and vascular dysfunction.	Hypertension	2012	53
22518004	11606	Matsusaka T	Liver angiotensinogen is the primary source of renal angiotensin II.	Journal of the American Society of Nephrology 	2012	62
23108647	11606	Yiannikouris F	Adipocyte deficiency of angiotensinogen prevents obesity-induced hypertension in male mice.	Hypertension	2012	32
24718617	11606	Li L	Opposite effects of gene deficiency and pharmacological inhibition of soluble epoxide hydrolase on cardiac fibrosis.	PloS one	2014	20
12897203	11625	Schafer C	The serum protein alpha 2-Heremans-Schmid glycoprotein/fetuin-A is a systemically acting inhibitor of ectopic calcification.	The Journal of clinical investigation	2003	134
21659653	11625	Jahnen-Dechent W	Fetuin-A regulation of calcified matrix metabolism.	Circulation research	2011	56
10673259	11651	Fujio Y	Akt promotes survival of cardiomyocytes in vitro and protects against ischemia-reperfusion injury in mouse heart.	Circulation	2000	192
11544177	11651	Chen WS	Growth retardation and increased apoptosis in mice with homozygous disruption of the Akt1 gene.	Genes and development	2001	253
11850850	11651	Gottlieb TM	Cross-talk between Akt, p53 and Mdm2: possible implications for the regulation of apoptosis.	Oncogene	2002	104
12649187	11651	Blaskovich MA	Discovery of JSI-124 (cucurbitacin I), a selective Janus kinase/signal transducer and activator of transcription 3 signaling pathway inhibitor with potent antitumor activity against human and murine cancer cells in mice.	Cancer research	2003	162
12799464	11651	Majumder PK	Prostate intraepithelial neoplasia induced by prostate restricted Akt activation: the MPAKT model.	Proceedings of the National Academy of Sciences of the United States of America	2003	99
12808134	11651	Jiang ZY	Insulin signaling through Akt/protein kinase B analyzed by small interfering RNA-mediated gene silencing.	Proceedings of the National Academy of Sciences of the United States of America	2003	94
14604847	11651	Minshall RD	Caveolin regulation of endothelial function.	American journal of physiology. Lung cellular and molecular physiology	2003	78
16777975	11651	Wang X	Insulin resistance accelerates muscle protein degradation: Activation of the ubiquitin-proteasome pathway by defects in muscle cell signaling.	Endocrinology	2006	108
17360480	11651	Zhang WJ	Alpha-lipoic acid attenuates LPS-induced inflammatory responses by activating the phosphoinositide 3-kinase/Akt signaling pathway.	Proceedings of the National Academy of Sciences of the United States of America	2007	65
18718903	11651	Ouchi N	Follistatin-like 1, a secreted muscle protein, promotes endothelial cell function and revascularization in ischemic tissue through a nitric-oxide synthase-dependent mechanism.	The Journal of biological chemistry	2008	76
20709750	11651	Wijesekara N	Adiponectin-induced ERK and Akt phosphorylation protects against pancreatic beta cell apoptosis and increases insulin gene expression and secretion.	The Journal of biological chemistry	2010	40
21161163	11651	Yu Z	Oltipraz upregulates the nuclear factor (erythroid-derived 2)-like 2 corrected(NRF2) antioxidant system and prevents insulin resistance and obesity induced by a high-fat diet in C57BL/6J mice.	Diabetologia	2011	37
21350002	11651	Boreddy SR	Pancreatic tumor suppression by benzyl isothiocyanate is associated with inhibition of PI3K/AKT/FOXO pathway.	Clinical cancer research 	2011	44
22003059	11651	Chatterjee S	Membrane depolarization is the trigger for PI3K/Akt activation and leads to the generation of ROS.	American journal of physiology. Heart and circulatory physiology	2012	36
22004992	11651	Jitrapakdee S	Transcription factors and coactivators controlling nutrient and hormonal regulation of hepatic gluconeogenesis.	The international journal of biochemistry and cell biology	2012	31
22622501	11651	Zhou D	Tubule-specific ablation of endogenous Î²-catenin aggravates acute kidney injury in mice.	Kidney international	2012	33
22773877	11651	Yuan M	Identification of Akt-independent regulation of hepatic lipogenesis by mammalian target of rapamycin (mTOR) complex 2.	The Journal of biological chemistry	2012	43
22927428	11651	El Kebir D	Resolvin E1 promotes phagocytosis-induced neutrophil apoptosis and accelerates resolution of pulmonary inflammation.	Proceedings of the National Academy of Sciences of the United States of America	2012	52
24490809	11651	Zeng Y	The DPP-4 inhibitor sitagliptin attenuates the progress of atherosclerosis in apolipoprotein-E-knockout mice via AMPK- and MAPK-dependent mechanisms.	Cardiovascular diabetology	2014	22
1102604	11657	Kessler SW	Rapid isolation of antigens from cells with a staphylococcal protein A-antibody adsorbent: parameters of the interaction of antibody-antigen complexes with protein A.	Journal of immunology	1975	861
11479625	11657	Mercer DF	Hepatitis C virus replication in mice with chimeric human livers.	Nature medicine	2001	220
20092887	11657	Xie J	PET/NIRF/MRI triple functional iron oxide nanoparticles.	Biomaterials	2010	80
20472598	11657	Verri WA Jr	IL-33 induces neutrophil migration in rheumatoid arthritis and is a target of anti-TNF therapy.	Annals of the rheumatic diseases	2010	49
22327491	11657	Joshi A	Immunization with Staphylococcus aureus iron regulated surface determinant B (IsdB) confers protection via Th17/IL17 pathway in a murine sepsis model.	Human vaccines and immunotherapeutics	2012	37
25363772	11657	Barzel A	Promoterless gene targeting without nucleases ameliorates haemophilia B in mice.	Nature	2015	39
11385507	11770	Makowski L	Lack of macrophage fatty-acid-binding protein aP2 protects mice deficient in apolipoprotein E against atherosclerosis.	Nature medicine	2001	165
16423904	11770	Xu A	Adipocyte fatty acid-binding protein is a plasma biomarker closely associated with obesity and metabolic syndrome.	Clinical chemistry	2006	96
23052058	11770	Kralisch S	Adipocyte fatty acid binding protein: a novel adipokine involved in the pathogenesis of metabolic and vascular disease?	Diabetologia	2013	31
23991091	11770	Miller AM	MiR-155 has a protective role in the development of non-alcoholic hepatosteatosis in mice.	PloS one	2013	32
15525940	11793	Kuma A	The role of autophagy during the early neonatal starvation period.	Nature	2004	833
18253089	11793	Wu YT	Autophagy plays a protective role during zVAD-induced necrotic cell death.	Autophagy	2008	56
21493778	11793	Kimura T	Autophagy protects the proximal tubule from degeneration and acute ischemic injury.	Journal of the American Society of Nephrology 	2011	89
23327930	11793	Conway KL	ATG5 regulates plasma cell differentiation.	Autophagy	2013	33
23354484	11793	Pengo N	Plasma cells require autophagy for sustainable immunoglobulin production.	Nature immunology	2013	61
26325539	11793	Ilyas G	Macrophage autophagy limits acute toxic liver injury in mice through down regulation of interleukin-1Î².	Journal of hepatology	2016	10
27096368	11793	Martinez J	Noncanonical autophagy inhibits the autoinflammatory, lupus-like response to dying cells.	Nature	2016	26
11804981	11806	Navab M	Oral administration of an Apo A-I mimetic Peptide synthesized from D-amino acids dramatically reduces atherosclerosis in mice independent of plasma cholesterol.	Circulation	2002	106
12900335	11806	Zhang Y	Overexpression of apolipoprotein A-I promotes reverse transport of cholesterol from macrophages to feces in vivo.	Circulation	2003	108
15197147	11806	Navab M	Oral D-4F causes formation of pre-beta high-density lipoprotein and improves high-density lipoprotein-mediated cholesterol efflux and reverse cholesterol transport from macrophages in apolipoprotein E-null mice.	Circulation	2004	88
19286630	11806	Wilhelm AJ	Apolipoprotein A-I and its role in lymphocyte cholesterol homeostasis and autoimmunity.	Arteriosclerosis, thrombosis, and vascular biology	2009	45
20480549	11806	Rothblat GH	High-density lipoprotein heterogeneity and function in reverse cholesterol transport.	Current opinion in lipidology	2010	97
21041624	11806	Su F	Apolipoprotein A-I (apoA-I) and apoA-I mimetic peptides inhibit tumor development in a mouse model of ovarian cancer.	Proceedings of the National Academy of Sciences of the United States of America	2010	49
22431312	11806	Besler C	Molecular mechanisms of vascular effects of High-density lipoprotein: alterations in cardiovascular disease.	EMBO molecular medicine	2012	41
24407029	11806	Hewing B	Effects of native and myeloperoxidase-modified apolipoprotein a-I on reverse cholesterol transport and atherosclerosis in mice.	Arteriosclerosis, thrombosis, and vascular biology	2014	22
25993337	11806	Kasumov T	Ceramide as a mediator of non-alcoholic Fatty liver disease and associated atherosclerosis.	PloS one	2015	16
1411543	11816	Zhang SH	Spontaneous hypercholesterolemia and arterial lesions in mice lacking apolipoprotein E.	Science	1992	440
1423598	11816	Plump AS	Severe hypercholesterolemia and atherosclerosis in apolipoprotein E-deficient mice created by homologous recombination in ES cells.	Cell	1992	419
1584779	11816	Piedrahita JA	Generation of mice carrying a mutant apolipoprotein E gene inactivated by gene targeting in embryonic stem cells.	Proceedings of the National Academy of Sciences of the United States of America	1992	200
7667279	11816	Smith JD	Decreased atherosclerosis in mice deficient in both macrophage colony-stimulating factor (op) and apolipoprotein E.	Proceedings of the National Academy of Sciences of the United States of America	1995	131
8274470	11816	Reddick RL	Atherosclerosis in mice lacking apo E. Evaluation of lesional development and progression.	Arteriosclerosis and thrombosis 	1994	138
8656070	11816	Tangirala RK	Quantitation of atherosclerosis in murine models: correlation between lesions in the aortic origin and in the entire aorta, and differences in the extent of lesions between sexes in LDL receptor-deficient and apolipoprotein E-deficient mice.	Journal of lipid research	1995	117
8698873	11816	Palinski W	Cloning of monoclonal autoantibodies to epitopes of oxidized lipoproteins from apolipoprotein E-deficient mice. Demonstration of epitopes of oxidized low density lipoprotein in human plasma.	The Journal of clinical investigation	1996	111
9069289	11816	Suzuki H	A role for macrophage scavenger receptors in atherosclerosis and susceptibility to infection.	Nature	1997	214
9169506	11816	Gupta S	IFN-gamma potentiates atherosclerosis in ApoE knock-out mice.	The Journal of clinical investigation	1997	160
9218423	11816	Sullivan PM	Targeted replacement of the mouse apolipoprotein E gene with the common human APOE3 allele enhances diet-induced hypercholesterolemia and atherosclerosis.	The Journal of biological chemistry	1997	137
9261096	11816	Ji Y	Scavenger receptor BI promotes high density lipoprotein-mediated cellular cholesterol efflux.	The Journal of biological chemistry	1997	108
9541487	11816	Aviram M	Paraoxonase inhibits high-density lipoprotein oxidation and preserves its functions. A possible peroxidative role for paraoxonase.	The Journal of clinical investigation	1998	151
9598845	11816	Nakashima Y	Upregulation of VCAM-1 and ICAM-1 at atherosclerosis-prone sites on the endothelium in the ApoE-deficient mouse.	Arteriosclerosis, thrombosis, and vascular biology	1998	152
9732872	11816	Boring L	Decreased lesion formation in CCR2-/- mice reveals a role for chemokines in the initiation of atherosclerosis.	Nature	1998	335
9884341	11816	HÃ¶rkkÃ¶ S	Monoclonal autoantibodies specific for oxidized phospholipids or oxidized phospholipid-protein adducts inhibit macrophage uptake of oxidized low-density lipoproteins.	The Journal of clinical investigation	1999	109
10430941	11816	Trigatti B	Influence of the high density lipoprotein receptor SR-BI on reproductive and cardiovascular pathophysiology.	Proceedings of the National Academy of Sciences of the United States of America	1999	112
10521365	11816	Huber SA	Interleukin-6 exacerbates early atherosclerosis in mice.	Arteriosclerosis, thrombosis, and vascular biology	1999	98
10841519	11816	Daugherty A	Angiotensin II promotes atherosclerotic lesions and aneurysms in apolipoprotein E-deficient mice.	The Journal of clinical investigation	2000	292
12097330	11816	Grefhorst A	Stimulation of lipogenesis by pharmacological activation of the liver X receptor leads to production of large, triglyceride-rich very low density lipoprotein particles.	The Journal of biological chemistry	2002	108
12431986	11816	Yamauchi T	Globular adiponectin protected ob/ob mice from diabetes and ApoE-deficient mice from atherosclerosis.	The Journal of biological chemistry	2003	169
12816879	11816	Lalla E	Oral infection with a periodontal pathogen accelerates early atherosclerosis in apolipoprotein E-null mice.	Arteriosclerosis, thrombosis, and vascular biology	2003	76
14744975	11816	Paul A	C-reactive protein accelerates the progression of atherosclerosis in apolipoprotein E-deficient mice.	Circulation	2004	71
15372102	11816	Kobayashi T	Roles of thromboxane A(2) and prostacyclin in the development of atherosclerosis in apoE-deficient mice.	The Journal of clinical investigation	2004	88
15590644	11816	Hojjati MR	Effect of myriocin on plasma sphingolipid metabolism and atherosclerosis in apoE-deficient mice.	The Journal of biological chemistry	2005	66
15788759	11816	Lim GP	A diet enriched with the omega-3 fatty acid docosahexaenoic acid reduces amyloid burden in an aged Alzheimer mouse model.	The Journal of neuroscience 	2005	124
16103409	11816	Hermanowski-Vosatka A	11beta-HSD1 inhibition ameliorates metabolic syndrome and prevents progression of atherosclerosis in mice.	The Journal of experimental medicine	2005	74
16840715	11816	Bennett BJ	Osteoprotegerin inactivation accelerates advanced atherosclerotic lesion progression and calcification in older ApoE-/- mice.	Arteriosclerosis, thrombosis, and vascular biology	2006	67
17339547	11816	Hansmann G	Pulmonary arterial hypertension is linked to insulin resistance and reversed by peroxisome proliferator-activated receptor-gamma activation.	Circulation	2007	122
17470698	11816	Bot I	Perivascular mast cells promote atherogenesis and induce plaque destabilization in apolipoprotein E-deficient mice.	Circulation	2007	63
17991878	11816	Okamoto Y	Adiponectin inhibits the production of CXC receptor 3 chemokine ligands in macrophages and reduces T-lymphocyte recruitment in atherogenesis.	Circulation research	2008	63
18202315	11816	Araujo JA	Ambient particulate pollutants in the ultrafine range promote early atherosclerosis and systemic oxidative stress.	Circulation research	2008	121
18212290	11816	Ohman MK	Visceral adipose tissue inflammation accelerates atherosclerosis in apolipoprotein E-deficient mice.	Circulation	2008	51
18268038	11816	Miller AM	IL-33 reduces the development of atherosclerosis.	The Journal of experimental medicine	2008	149
18541740	11816	Briley-Saebo KC	Targeted molecular probes for imaging atherosclerotic lesions with magnetic resonance using antibodies that recognize oxidation-specific epitopes.	Circulation	2008	55
18658050	11816	Rocha VZ	Interferon-gamma, a Th1 cytokine, regulates fat inflammation: a role for adaptive immunity in obesity.	Circulation research	2008	137
18987181	11816	Riddell DR	Impact of apolipoprotein E (ApoE) polymorphism on brain ApoE levels.	The Journal of neuroscience 	2008	87
18988885	11816	Wang Y	Role of hydrogen sulfide in the development of atherosclerotic lesions in apolipoprotein E knockout mice.	Arteriosclerosis, thrombosis, and vascular biology	2009	60
19139167	11816	GrÃ¤bner R	Lymphotoxin beta receptor signaling promotes tertiary lymphoid organogenesis in the aorta adventitia of aged ApoE-/- mice.	The Journal of experimental medicine	2009	80
19416717	11816	Thorp E	Reduced apoptosis and plaque necrosis in advanced atherosclerotic lesions of Apoe-/- and Ldlr-/- mice lacking CHOP.	Cell metabolism	2009	114
19474305	11816	Bales KR	Human APOE isoform-dependent effects on brain beta-amyloid levels in PDAPP transgenic mice.	The Journal of neuroscience 	2009	87
19487682	11816	Peters D	Targeting atherosclerosis by using modular, multifunctional micelles.	Proceedings of the National Academy of Sciences of the United States of America	2009	59
19577821	11816	Sullivan PM	Reduced levels of human apoE4 protein in an animal model of cognitive impairment.	Neurobiology of aging	2011	37
19620505	11816	Croce K	Myeloid-related protein-8/14 is critical for the biological response to vascular injury.	Circulation	2009	62
19667236	11816	Norata GD	Deficiency of the long pentraxin PTX3 promotes vascular inflammation and atherosclerosis.	Circulation	2009	67
19837950	11816	Judkins CP	Direct evidence of a role for Nox2 in superoxide production, reduced nitric oxide bioavailability, and early atherosclerotic plaque formation in ApoE-/- mice.	American journal of physiology. Heart and circulatory physiology	2010	87
19897196	11816	Jun J	Effect of intermittent hypoxia on atherosclerosis in apolipoprotein E-deficient mice.	Atherosclerosis	2010	51
20368519	11816	Smith E	Blockade of interleukin-17A results in reduced atherosclerosis in apolipoprotein E-deficient mice.	Circulation	2010	120
20444418	11816	Rask-Madsen C	Loss of insulin signaling in vascular endothelial cells accelerates atherosclerosis in apolipoprotein E null mice.	Cell metabolism	2010	80
20460915	11816	Trauner M	Bile acids as regulators of hepatic lipid and glucose metabolism.	Digestive diseases	2010	58
20854843	11816	Hauser PS	Apolipoprotein E: from lipid transport to neurobiology.	Progress in lipid research	2011	54
20947824	11816	Skoura A	Sphingosine-1-phosphate receptor-2 function in myeloid cells regulates vascular inflammation and atherosclerosis.	Arteriosclerosis, thrombosis, and vascular biology	2011	39
20947826	11816	Barajas B	NF-E2-related factor 2 promotes atherosclerosis by effects on plasma lipoproteins and cholesterol transport that overshadow antioxidant protection.	Arteriosclerosis, thrombosis, and vascular biology	2011	35
21350196	11816	Baitsch D	Apolipoprotein E induces antiinflammatory phenotype in macrophages.	Arteriosclerosis, thrombosis, and vascular biology	2011	57
21482781	11816	Feig JE	HDL promotes rapid atherosclerosis regression in mice and alters inflammatory properties of plaque monocyte-derived cells.	Proceedings of the National Academy of Sciences of the United States of America	2011	86
21505265	11816	Potteaux S	Suppressed monocyte recruitment drives macrophage removal from atherosclerotic plaques of Apoe-/- mice during disease regression.	The Journal of clinical investigation	2011	93
21868694	11816	Kyaw T	B1a B lymphocytes are atheroprotective by secreting natural IgM that increases IgM deposits and reduces necrotic cores in atherosclerotic lesions.	Circulation research	2011	68
22240132	11816	Matsubara J	A dipeptidyl peptidase-4 inhibitor, des-fluoro-sitagliptin, improves endothelial function and reduces atherosclerotic lesion formation in apolipoprotein E-deficient mice.	Journal of the American College of Cardiology	2012	61
23183176	11816	Panjwani N	GLP-1 receptor activation indirectly reduces hepatic lipid accumulation but does not attenuate development of atherosclerosis in diabetic male ApoE(-/-) mice.	Endocrinology	2013	52
23337530	11816	Ervinna N	Anagliptin, a DPP-4 inhibitor, suppresses proliferation of vascular smooth muscles and monocyte inflammatory reaction and attenuates atherosclerosis in male apo E-deficient mice.	Endocrinology	2013	30
23349943	11816	Weng S	Vitamin D deficiency induces high blood pressure and accelerates atherosclerosis in mice.	PloS one	2013	27
23524964	11816	Martel C	Lymphatic vasculature mediates macrophage reverse cholesterol transport in mice.	The Journal of clinical investigation	2013	52
23999527	11816	Hammer C	Neuropsychiatric disease relevance of circulating anti-NMDA receptor autoantibodies depends on blood-brain barrier integrity.	Molecular psychiatry	2014	54
24084690	11816	Sun X	Systemic delivery of microRNA-181b inhibits nuclear factor-ÎºB activation, vascular inflammation, and atherosclerosis in apolipoprotein E-deficient mice.	Circulation research	2014	50
25754609	11816	BerbÃ©e JF	Brown fat activation reduces hypercholesterolaemia and protects from atherosclerosis development.	Nature communications	2015	23
25904598	11816	Li K	Apolipoprotein E enhances microRNA-146a in monocytes and macrophages to suppress nuclear factor-ÎºB-driven inflammation and atherosclerosis.	Circulation research	2015	17
10408445	11820	Schenk D	Immunization with amyloid-beta attenuates Alzheimer-disease-like pathology in the PDAPP mouse.	Nature	1999	574
11160418	11820	Kawarabayashi T	Age-dependent changes in brain, CSF, and plasma amyloid (beta) protein in the Tg2576 transgenic mouse model of Alzheimer's disease.	The Journal of neuroscience 	2001	299
11438712	11820	DeMattos RB	Peripheral anti-A beta antibody alters CNS and plasma A beta clearance and decreases brain A beta burden in a mouse model of Alzheimer's disease.	Proceedings of the National Academy of Sciences of the United States of America	2001	272
12695498	11820	Anandatheerthavarada HK	Mitochondrial targeting and a novel transmembrane arrest of Alzheimer's amyloid precursor protein impairs mitochondrial function in neuronal cells.	The Journal of cell biology	2003	115
16147975	11820	Torosantucci A	A novel glyco-conjugate vaccine against fungal pathogens.	The Journal of experimental medicine	2005	86
16365303	11820	Yue X	Brain estrogen deficiency accelerates Abeta plaque formation in an Alzheimer's disease animal model.	Proceedings of the National Academy of Sciences of the United States of America	2005	80
18562603	11820	Maier M	Complement C3 deficiency leads to accelerated amyloid beta plaque deposition and neurodegeneration and modulation of the microglia/macrophage phenotype in amyloid precursor protein transgenic mice.	The Journal of neuroscience 	2008	83
19275634	11820	Deane R	Clearance of amyloid-beta peptide across the blood-brain barrier: implication for therapies in Alzheimer's disease.	CNS and neurological disorders drug targets	2009	101
19622727	11820	Eisele YS	Induction of cerebral beta-amyloidosis: intracerebral versus systemic Abeta inoculation.	Proceedings of the National Academy of Sciences of the United States of America	2009	75
20308787	11820	Li Y	GLP-1 receptor stimulation reduces amyloid-beta peptide accumulation and cytotoxicity in cellular and animal models of Alzheimer's disease.	Journal of Alzheimer's disease 	2010	61
21747957	11820	Yao J	2-Deoxy-D-glucose treatment induces ketogenesis, sustains mitochondrial function, and reduces pathology in female mouse model of Alzheimer's disease.	PloS one	2011	36
22046307	11820	Westmark CJ	Reversal of fragile X phenotypes by manipulation of AÎ²PP/AÎ² levels in Fmr1KO mice.	PloS one	2011	42
9468475	11826	Ma T	Severely impaired urinary concentrating ability in transgenic mice lacking aquaporin-1 water channels.	The Journal of biological chemistry	1998	109
11919508	11826	Badaut J	Aquaporins in brain: distribution, physiology, and pathophysiology.	Journal of cerebral blood flow and metabolism 	2002	84
16818469	11826	Hu J	Increased migration and metastatic potential of tumor cells expressing aquaporin water channels.	FASEB journal 	2006	75
17968585	11826	Papadopoulos MC	Aquaporins and cell migration.	Pflugers Archiv 	2008	72
18311471	11826	Verkman AS	Aquaporins--new players in cancer biology.	Journal of molecular medicine	2008	58
19085041	11826	Ishibashi K	Aquaporin water channels in mammals.	Clinical and experimental nephrology	2009	51
11773613	11827	Nielsen S	Aquaporins in the kidney: from molecules to medicine.	Physiological reviews	2002	205
17575258	11827	Rieg T	Mice lacking P2Y2 receptors have salt-resistant hypertension and facilitated renal Na+ and water reabsorption.	FASEB journal 	2007	80
18606813	11827	Hoffert JD	Vasopressin-stimulated increase in phosphorylation at Ser269 potentiates plasma membrane retention of aquaporin-2.	The Journal of biological chemistry	2008	73
9276712	11829	Ma T	Generation and phenotype of a transgenic knockout mouse lacking the mercurial-insensitive water channel aquaporin-4.	The Journal of clinical investigation	1997	111
16303850	11829	Saadoun S	Involvement of aquaporin-4 in astroglial cell migration and glial scar formation.	Journal of cell science	2005	115
17928579	11829	Hinson SR	Pathogenic potential of IgG binding to water channel extracellular domain in neuromyelitis optica.	Neurology	2007	110
21257712	11829	Li L	Proinflammatory role of aquaporin-4 in autoimmune neuroinflammation.	FASEB journal 	2011	42
22069219	11829	Zhang H	Ex vivo spinal cord slice model of neuromyelitis optica reveals novel immunopathogenic mechanisms.	Annals of neurology	2011	49
22271321	11829	Tradtrantip L	Anti-aquaporin-4 monoclonal antibody blocker therapy for neuromyelitis optica.	Annals of neurology	2012	61
22374891	11829	Saadoun S	Neutrophil protease inhibition reduces neuromyelitis optica-immunoglobulin G-induced damage in mouse brain.	Annals of neurology	2012	51
23055279	11829	Tradtrantip L	Enzymatic deglycosylation converts pathogenic neuromyelitis optica anti-aquaporin-4 immunoglobulin G into therapeutic antibody.	Annals of neurology	2013	26
12370412	11835	Yeh S	Generation and characterization of androgen receptor knockout (ARKO) mice: an in vivo model for the study of androgen functions in selective tissues.	Proceedings of the National Academy of Sciences of the United States of America	2002	136
15107499	11835	Chang C	Infertility with defective spermatogenesis and hypotestosteronemia in male mice lacking the androgen receptor in Sertoli cells.	Proceedings of the National Academy of Sciences of the United States of America	2004	101
17334372	11835	Yang Z	ASC-J9 ameliorates spinal and bulbar muscular atrophy phenotype via degradation of androgen receptor.	Nature medicine	2007	56
18639551	11835	Ma WL	Androgen receptor is a new potential therapeutic target for the treatment of hepatocellular carcinoma.	Gastroenterology	2008	55
19357272	11835	Raskin K	Conditional inactivation of androgen receptor gene in the nervous system: effects on male behavioral and neuroendocrine responses.	The Journal of neuroscience 	2009	55
23399021	11835	Guo W	Testosterone administration inhibits hepcidin transcription and is associated with increased iron incorporation into red blood cells.	Aging cell	2013	30
25202834	11835	Vanderschueren D	Sex steroid actions in male bone.	Endocrine reviews	2014	34
27232975	11835	DeRita RM	c-Src, Insulin-Like Growth Factor I Receptor, G-Protein-Coupled Receptor Kinases and Focal Adhesion Kinase are Enriched Into Prostate Cancer Cell Exosomes.	Journal of cellular biochemistry	2017	5
11152753	11941	Strehler EE	Role of alternative splicing in generating isoform diversity among plasma membrane calcium pumps.	Physiological reviews	2001	122
19339464	11941	Lelli A	Tonotopic gradient in the developmental acquisition of sensory transduction in outer hair cells of the mouse cochlea.	Journal of neurophysiology	2009	62
16505490	12028	Malhi H	Free fatty acids induce JNK-dependent hepatocyte lipoapoptosis.	The Journal of biological chemistry	2006	163
16831600	12028	Gunawan BK	c-Jun N-terminal kinase plays a major role in murine acetaminophen hepatotoxicity.	Gastroenterology	2006	133
17079463	12028	Chen D	Disulfiram, a clinically used anti-alcoholism drug and copper-binding agent, induces apoptotic cell death in breast cancer cultures and xenografts via inhibition of the proteasome activity.	Cancer research	2006	91
17135272	12028	Wang X	Carbon monoxide protects against hyperoxia-induced endothelial cell apoptosis by inhibiting reactive oxygen species formation.	The Journal of biological chemistry	2007	57
17410096	12028	Wei Q	The pathological role of Bax in cisplatin nephrotoxicity.	Kidney international	2007	57
17906064	12028	Bajt ML	Mitochondrial bax translocation accelerates DNA fragmentation and cell necrosis in a murine model of acetaminophen hepatotoxicity.	The Journal of pharmacology and experimental therapeutics	2008	55
23531302	12028	Nasir GA	Mesenchymal stem cells and Interleukin-6 attenuate liver fibrosis in mice.	Journal of translational medicine	2013	30
15133062	12064	Sudo N	Postnatal microbial colonization programs the hypothalamic-pituitary-adrenal system for stress response in mice.	The Journal of physiology	2004	211
16519925	12064	Song L	Impairment of the spatial learning and memory induced by learned helplessness and chronic mild stress.	Pharmacology, biochemistry, and behavior	2006	65
19666694	12064	Rasmussen P	Evidence for a release of brain-derived neurotrophic factor from the brain during exercise.	Experimental physiology	2009	105
20600016	12064	Bercik P	Chronic gastrointestinal inflammation induces anxiety-like behavior and alters central nervous system biochemistry in mice.	Gastroenterology	2010	70
20603014	12064	Cao L	Environmental and genetic activation of a brain-adipocyte BDNF/leptin axis causes cancer remission and inhibition.	Cell	2010	67
20604989	12064	Klein AB	Blood BDNF concentrations reflect brain-tissue BDNF levels across species.	The international journal of neuropsychopharmacology	2011	69
20686454	12064	Schmidt HD	Peripheral BDNF produces antidepressant-like effects in cellular and behavioral models.	Neuropsychopharmacology 	2010	84
21949705	12064	Dinel AL	Cognitive and emotional alterations are related to hippocampal inflammation in a mouse model of metabolic syndrome.	PloS one	2011	35
22152994	12064	ThÃ¶ne J	Modulation of autoimmune demyelination by laquinimod via induction of brain-derived neurotrophic factor.	The American journal of pathology	2012	30
22442074	12064	Yu H	Variant brain-derived neurotrophic factor Val66Met polymorphism alters vulnerability to stress and response to antidepressants.	The Journal of neuroscience 	2012	62
25600109	12064	Lin LC	Somatostatin, neuronal vulnerability and behavioral emotionality.	Molecular psychiatry	2015	19
26019015	12064	Kamat PK	Hydrogen Sulfide Ameliorates Homocysteine-Induced Alzheimer's Disease-Like Pathology, Blood-Brain Barrier Disruption, and Synaptic Disorder.	Molecular neurobiology	2016	11
9664068	12097	Weinstein RS	Inhibition of osteoblastogenesis and promotion of apoptosis of osteoblasts and osteocytes by glucocorticoids. Potential mechanisms of their deleterious effects on bone.	The Journal of clinical investigation	1998	208
19063687	12097	Kindblom JM	Plasma osteocalcin is inversely related to fat mass and plasma glucose in elderly Swedish men.	Journal of bone and mineral research 	2009	69
21957195	12097	Frisch BJ	Functional inhibition of osteoblastic cells in an in vivo mouse model of myeloid leukemia.	Blood	2012	44
25503693	12097	Xu W	The systemic delivery of an oncolytic adenovirus expressing decorin inhibits bone metastasis in a mouse model of human prostate cancer.	Gene therapy	2015	17
25802278	12097	Frey JL	Wnt-Lrp5 signaling regulates fatty acid metabolism in the osteoblast.	Molecular and cellular biology	2015	16
14563324	12142	Shapiro-Shelef M	Blimp-1 is required for the formation of immunoglobulin secreting plasma cells and pre-plasma memory B cells.	Immunity	2003	198
15345222	12142	Shaffer AL	XBP1, downstream of Blimp-1, expands the secretory apparatus and other organelles, and increases protein synthesis in plasma cell differentiation.	Immunity	2004	263
15492122	12142	Kallies A	Plasma cell ontogeny defined by quantitative changes in blimp-1 expression.	The Journal of experimental medicine	2004	108
16314438	12142	Shapiro-Shelef M	Blimp-1 is required for maintenance of long-lived plasma cells in the bone marrow.	The Journal of experimental medicine	2005	67
16565721	12142	Martins GA	Transcriptional repressor Blimp-1 regulates T cell homeostasis and function.	Nature immunology	2006	109
17000121	12142	Omori SA	Regulation of class-switch recombination and plasma cell differentiation by phosphatidylinositol 3-kinase signaling.	Immunity	2006	64
17509907	12142	Kallies A	Initiation of plasma-cell differentiation is independent of the transcription factor Blimp-1.	Immunity	2007	57
17548615	12142	Genestier L	TLR agonists selectively promote terminal plasma cell differentiation of B cell subsets specialized in thymus-independent responses.	Journal of immunology	2007	86
18222702	12142	Fairfax KA	Plasma cell development: from B-cell subsets to long-term survival niches.	Seminars in immunology	2008	54
19407814	12142	Hu CC	XBP-1 regulates signal transduction, transcription factors and bone marrow colonization in B cells.	The EMBO journal	2009	54
19410550	12142	Ohinata Y	A signaling principle for the specification of the germ cell lineage in mice.	Cell	2009	77
20064451	12142	Kwon H	Analysis of interleukin-21-induced Prdm1 gene regulation reveals functional cooperation of STAT3 and IRF4 transcription factors.	Immunity	2009	123
21131593	12142	Kallies A	A role for Blimp1 in the transcriptional network controlling natural killer cell maturation.	Blood	2011	40
21156281	12142	Mandelbaum J	BLIMP1 is a tumor suppressor gene frequently disrupted in activated B cell-like diffuse large B cell lymphoma.	Cancer cell	2010	64
21156282	12142	Calado DP	Constitutive canonical NF-ÎºB activation cooperates with disruption of BLIMP1 in the pathogenesis of activated B cell-like diffuse large cell lymphoma.	Cancer cell	2010	46
21948081	12142	Kim SJ	Tolerogenic function of Blimp-1 in dendritic cells.	The Journal of experimental medicine	2011	40
22406270	12142	Yang Z	Fluorescent in vivo detection reveals that IgE(+) B cells are restrained by an intrinsic cell fate predisposition.	Immunity	2012	34
25484301	12142	Matsumoto M	Interleukin-10-producing plasmablasts exert regulatory function in autoimmune inflammation.	Immunity	2014	38
15879138	12259	Hart ML	Gastrointestinal ischemia-reperfusion injury is lectin complement pathway dependent without involving C1q.	Journal of immunology	2005	65
19414754	12259	Chen Y	IgM antibodies to apoptosis-associated determinants recruit C1q and enhance dendritic cell phagocytosis of apoptotic cells.	Journal of immunology	2009	63
19620499	12259	Lewis MJ	Immunoglobulin M is required for protection against atherosclerosis in low-density lipoprotein receptor-deficient mice.	Circulation	2009	62
20416309	12259	Cohen JI	Complement and alcoholic liver disease: role of C1q in the pathogenesis of ethanol-induced liver injury in mice.	Gastroenterology	2010	42
22682250	12259	Naito AT	Complement C1q activates canonical Wnt signaling and promotes aging-related phenotypes.	Cell	2012	50
23524342	12259	Xu Z	Coagulation factor X shields adenovirus type 5 from attack by natural antibodies and complement.	Nature medicine	2013	44
25679762	12259	Bonavita E	PTX3 is an extrinsic oncosuppressor regulating complement-dependent inflammation in cancer.	Cell	2015	34
10476219	12266	Ogris M	PEGylated DNA/transferrin-PEI complexes: reduced interaction with blood components, extended circulation in blood and potential for systemic gene delivery.	Gene therapy	1999	114
21346230	12266	Willis VC	N-Î±-benzoyl-N5-(2-chloro-1-iminoethyl)-L-ornithine amide, a protein arginine deiminase inhibitor, reduces the severity of murine collagen-induced arthritis.	Journal of immunology	2011	77
19265038	12359	Collins AR	Age-accelerated atherosclerosis correlates with failure to upregulate antioxidant genes.	Circulation research	2009	77
22315314	12359	Hwang I	Catalase deficiency accelerates diabetic renal injury through peroxisomal dysfunction.	Diabetes	2012	30
11342578	12362	Melnikov VY	Impaired IL-18 processing protects caspase-1-deficient mice from ischemic acute renal failure.	The Journal of clinical investigation	2001	101
12393844	12362	Melnikov VY	Neutrophil-independent mechanisms of caspase-1- and IL-18-mediated ischemic acute tubular necrosis in mice.	The Journal of clinical investigation	2002	93
17641058	12362	Qu Y	Nonclassical IL-1 beta secretion stimulated by P2X7 receptors is dependent on inflammasome activation and correlated with exosome release in murine macrophages.	Journal of immunology	2007	147
19950258	12362	Guma M	Caspase 1-independent activation of interleukin-1beta in neutrophil-predominant inflammation.	Arthritis and rheumatism	2009	77
20802146	12362	Lamkanfi M	Inflammasome-dependent release of the alarmin HMGB1 in endotoxemia.	Journal of immunology	2010	112
21622869	12362	Ather JL	Serum amyloid A activates the NLRP3 inflammasome and promotes Th17 allergic asthma in mice.	Journal of immunology	2011	59
21876127	12362	Stienstra R	Inflammasome is a central player in the induction of obesity and insulin resistance.	Proceedings of the National Academy of Sciences of the United States of America	2011	149
22411067	12362	Dixon LJ	Caspase-1-mediated regulation of fibrogenesis in diet-induced steatohepatitis.	Laboratory investigation; a journal of technical methods and pathology	2012	33
22461369	12362	Dolinay T	Inflammasome-regulated cytokines are critical mediators of acute lung injury.	American journal of respiratory and critical care medicine	2012	84
22987396	12362	Miura K	Toll-like receptor 2 and palmitic acid cooperatively contribute to the development of nonalcoholic steatohepatitis through inflammasome activation in mice.	Hepatology	2013	46
23409132	12362	Dixon LJ	Caspase-1 as a central regulator of high fat diet-induced non-alcoholic steatohepatitis.	PloS one	2013	29
24481253	12362	Bulau AM	Role of caspase-1 in nuclear translocation of IL-37, release of the cytokine, and IL-37 inhibition of innate immune responses.	Proceedings of the National Academy of Sciences of the United States of America	2014	25
25327779	12362	Kim HY	Activation of NLRP3 and AIM2 inflammasomes in Kupffer cells in hepatic ischemia/reperfusion.	The FEBS journal	2015	16
26659062	12362	GonzÃ¡lez-Juarbe N	Pore-Forming Toxins Induce Macrophage Necroptosis during Acute Bacterial Pneumonia.	PLoS pathogens	2015	17
12689915	12389	Frank PG	Caveolin, caveolae, and endothelial cell function.	Arteriosclerosis, thrombosis, and vascular biology	2003	77
14576179	12389	Combs TP	A transgenic mouse with a deletion in the collagenous domain of adiponectin displays elevated circulating adiponectin and improved insulin sensitivity.	Endocrinology	2004	120
15668297	12389	Kirkham M	Ultrastructural identification of uncoated caveolin-independent early endocytic vehicles.	The Journal of cell biology	2005	117
21497090	12389	Bosch M	Caveolin-1 deficiency causes cholesterol-dependent mitochondrial dysfunction and apoptotic susceptibility.	Current biology 	2011	46
22232608	12389	Sowa G	Caveolae, caveolins, cavins, and endothelial cell function: new insights.	Frontiers in physiology	2012	37
7878023	12411	Watanabe M	Mice deficient in cystathionine beta-synthase: animal models for mild and severe homocyst(e)inemia.	Proceedings of the National Academy of Sciences of the United States of America	1995	145
19474193	12411	Sen U	Hydrogen sulfide ameliorates hyperhomocysteinemia-associated chronic renal failure.	American journal of physiology. Renal physiology	2009	51
10623846	12475	Cario E	Lipopolysaccharide activates distinct signaling pathways in intestinal epithelial cell lines expressing Toll-like receptors.	Journal of immunology	2000	159
14979920	12475	Stein T	Involution of the mouse mammary gland is associated with an immune cascade and an acute-phase response, involving LBP, CD14 and STAT3.	Breast cancer research 	2004	111
15034566	12475	BjÃ¶rkbacka H	Reduced atherosclerosis in MyD88-null mice links elevated serum cholesterol levels to activation of innate immunity signaling pathways.	Nature medicine	2004	154
15833831	12475	Zea AH	Arginase-producing myeloid suppressor cells in renal cell carcinoma patients: a mechanism of tumor evasion.	Cancer research	2005	231
17456850	12475	Cani PD	Metabolic endotoxemia initiates obesity and insulin resistance.	Diabetes	2007	733
17657310	12475	Paulos CM	Microbial translocation augments the function of adoptively transferred self/tumor-specific CD8+ T cells via TLR4 signaling.	The Journal of clinical investigation	2007	123
18305141	12475	Cani PD	Changes in gut microbiota control metabolic endotoxemia-induced inflammation in high-fat diet-induced obesity and diabetes in mice.	Diabetes	2008	590
19115316	12475	Velayudham A	VSL#3 probiotic treatment attenuates fibrosis without changes in steatohepatitis in a diet-induced nonalcoholic steatohepatitis model in mice.	Hepatology	2009	59
7543183	12478	Rickert RC	Impairment of T-cell-dependent B-cell responses and B-1 cell development in CD19-deficient mice.	Nature	1995	127
17600736	12478	Pao LI	B cell-specific deletion of protein-tyrosine phosphatase Shp1 promotes B-1a cell development and causes systemic autoimmunity.	Immunity	2007	80
19752183	12478	Todd DJ	XBP1 governs late events in plasma cell differentiation and is not required for antigen-specific memory B cell development.	The Journal of experimental medicine	2009	57
21093320	12478	Belver L	MicroRNAs prevent the generation of autoreactive antibodies.	Immunity	2010	50
22009734	12478	Choi YS	B-1 cells in the bone marrow are a significant source of natural IgM.	European journal of immunology	2012	47
22733078	12478	Kim D	CD19-CD45 low/- CD38 high/CD138+ plasma cells enrich for human tumorigenic myeloma cells.	Leukemia	2012	33
15172969	12482	Teeling JL	Characterization of new human CD20 monoclonal antibodies with potent cytolytic activity against non-Hodgkin lymphomas.	Blood	2004	104
18097037	12482	DiLillo DJ	Maintenance of long-lived plasma cells and serological memory despite mature and memory B cell depletion during CD20 immunotherapy in mice.	Journal of immunology	2008	75
18172311	12482	Matsui W	Clonogenic multiple myeloma progenitors, stem cell properties, and drug resistance.	Cancer research	2008	163
20176942	12482	Huang H	Rituximab specifically depletes short-lived autoreactive plasma cells in a mouse model of inflammatory arthritis.	Proceedings of the National Academy of Sciences of the United States of America	2010	44
10383407	12491	Febbraio M	A null mutation in murine CD36 reveals an important role in fatty acid and lipoprotein metabolism.	The Journal of biological chemistry	1999	187
10772654	12491	Podrez EA	Macrophage scavenger receptor CD36 is the major receptor for LDL modified by monocyte-generated reactive nitrogen species.	The Journal of clinical investigation	2000	105
12145296	12491	Podrez EA	A novel family of atherogenic oxidized phospholipids promotes macrophage foam cell formation via the scavenger receptor CD36 and is enriched in atherosclerotic lesions.	The Journal of biological chemistry	2002	121
15841205	12491	Drover VA	CD36 deficiency impairs intestinal lipid secretion and clearance of chylomicrons from the blood.	The Journal of clinical investigation	2005	72
17721545	12491	Podrez EA	Platelet CD36 links hyperlipidemia, oxidant stress and a prothrombotic phenotype.	Nature medicine	2007	115
17728375	12491	Koonen DP	Increased hepatic CD36 expression contributes to dyslipidemia associated with diet-induced obesity.	Diabetes	2007	82
18065445	12491	Kuchibhotla S	Absence of CD36 protects against atherosclerosis in ApoE knock-out mice with no additional protection provided by absence of scavenger receptor A I/II.	Cardiovascular research	2008	55
23371517	12491	Ma Y	Synthetic FXR agonist GW4064 prevents diet-induced hepatic steatosis and insulin resistance.	Pharmaceutical research	2013	27
23812099	12491	Sheedy FJ	CD36 coordinates NLRP3 inflammasome activation by facilitating intracellular nucleation of soluble ligands into particulate ligands in sterile inflammation.	Nature immunology	2013	117
24412615	12491	Lim H	Proatherogenic conditions promote autoimmune T helper 17 cell responses in vivo.	Immunity	2014	24
26650570	12491	Wilson CG	Hepatocyte-Specific Disruption of CD36 Attenuates Fatty Liver and Improves Insulin Sensitivity in HFD-Fed Mice.	Endocrinology	2016	12
26853749	12491	Schlein C	FGF21 Lowers Plasma Triglycerides by Accelerating Lipoprotein Catabolism in White and Brown Adipose Tissues.	Cell metabolism	2016	15
1634608	12504	Tiegs G	A T cell-dependent experimental liver injury in mice inducible by concanavalin A.	The Journal of clinical investigation	1992	172
1909605	12504	Cosgrove D	Mice lacking MHC class II molecules.	Cell	1991	209
15448685	12504	Seo SK	4-1BB-mediated immunotherapy of rheumatoid arthritis.	Nature medicine	2004	97
16007534	12504	Kaufmann GR	Characteristics, determinants, and clinical relevance of CD4 T cell recovery to &amp;lt;500 cells/microL in HIV type 1-infected individuals receiving potent antiretroviral therapy.	Clinical infectious diseases 	2005	89
16477563	12504	Vasan A	Different rates of disease progression of HIV type 1 infection in Tanzania based on infecting subtype.	Clinical infectious diseases 	2006	69
16809617	12504	Dou H	Development of a macrophage-based nanoparticle platform for antiretroviral drug delivery.	Blood	2006	87
16849474	12504	Oertelt S	Anti-mitochondrial antibodies and primary biliary cirrhosis in TGF-beta receptor II dominant-negative mice.	Journal of immunology	2006	88
17035323	12504	Sitati EM	CD4+ T-cell responses are required for clearance of West Nile virus from the central nervous system.	Journal of virology	2006	95
17079441	12504	Pellegatta S	Neurospheres enriched in cancer stem-like cells are highly effective in eliciting a dendritic cell-mediated immune response against malignant gliomas.	Cancer research	2006	77
18032492	12504	Quan FS	Induction of heterosubtypic immunity to influenza virus by intranasal immunization.	Journal of virology	2008	67
18544681	12504	Jiang Q	FoxP3+CD4+ regulatory T cells play an important role in acute HIV-1 infection in humanized Rag2-/-gammaC-/- mice in vivo.	Blood	2008	57
19135996	12504	GonzÃ¡lez MA	Adipose-derived mesenchymal stem cells alleviate experimental colitis by inhibiting inflammatory and autoimmune responses.	Gastroenterology	2009	142
19143470	12504	Curtin JF	HMGB1 mediates endogenous TLR2 activation and brain tumor regression.	PLoS medicine	2009	117
19164169	12504	Robertson SA	Seminal fluid drives expansion of the CD4+CD25+ T regulatory cell pool and induces tolerance to paternal alloantigens in mice.	Biology of reproduction	2009	45
19625990	12504	Gandolfo MT	Foxp3+ regulatory T cells participate in repair of ischemic acute kidney injury.	Kidney international	2009	70
19836068	12504	Ivanov II	Induction of intestinal Th17 cells by segmented filamentous bacteria.	Cell	2009	933
19889972	12504	Cong Y	A dominant, coordinated T regulatory cell-IgA response to the intestinal microbiota.	Proceedings of the National Academy of Sciences of the United States of America	2009	111
19940103	12504	Singh UP	Resveratrol (trans-3,5,4'-trihydroxystilbene) induces silent mating type information regulation-1 and down-regulates nuclear transcription factor-kappaB activation to abrogate dextran sulfate sodium-induced colitis.	The Journal of pharmacology and experimental therapeutics	2010	45
20420510	12504	Asmuth DM	Safety, tolerability, and mechanisms of antiretroviral activity of pegylated interferon Alfa-2a in HIV-1-monoinfected participants: a phase II clinical trial.	The Journal of infectious diseases	2010	42
20640189	12504	Melchior B	Dual induction of TREM2 and tolerance-related transcript, Tmem176b, in amyloid transgenic mice: implications for vaccine-based therapies for Alzheimer's disease.	ASN neuro	2010	44
21160043	12504	Sun K	Seasonal FluMist vaccination induces cross-reactive T cell immunity against H1N1 (2009) influenza and secondary bacterial infections.	Journal of immunology	2011	40
21258338	12504	Aagaard C	A multistage tuberculosis vaccine that confers efficient protection before and after exposure.	Nature medicine	2011	137
21368026	12504	Dash PK	Loss of neuronal integrity during progressive HIV-1 infection of humanized mice.	The Journal of neuroscience 	2011	45
21543483	12504	Lazear HM	Beta interferon controls West Nile virus infection and pathogenesis in mice.	Journal of virology	2011	42
21544902	12504	Goodwin M	Bone marrow-derived mesenchymal stromal cells inhibit Th2-mediated allergic airways inflammation in mice.	Stem cells	2011	43
21628568	12504	Finco O	Approach to discover T- and B-cell antigens of intracellular pathogens applied to the design of Chlamydia trachomatis vaccines.	Proceedings of the National Academy of Sciences of the United States of America	2011	36
22308272	12504	Ruel TD	Neurocognitive and motor deficits in HIV-infected Ugandan children with high CD4 cell counts.	Clinical infectious diseases 	2012	31
22688334	12504	Bassi ÃJ	Immune regulatory properties of allogeneic adipose-derived mesenchymal stem cells in the treatment of experimental autoimmune diabetes.	Diabetes	2012	35
22750327	12504	Watson MB	Regionally-specific microglial activation in young mice over-expressing human wildtype alpha-synuclein.	Experimental neurology	2012	36
22966002	12504	Chappell CP	Extrafollicular B cell activation by marginal zone dendritic cells drives T cell-dependent antibody responses.	The Journal of experimental medicine	2012	32
23020860	12504	Walker PA	Intravenous multipotent adult progenitor cell therapy after traumatic brain injury: modulation of the resident microglia population.	Journal of neuroinflammation	2012	32
23263488	12504	Trynka G	Chromatin marks identify critical cell types for fine mapping complex trait variants.	Nature genetics	2013	129
23467095	12504	Kleinewietfeld M	Sodium chloride drives autoimmune disease by the induction of pathogenic TH17 cells.	Nature	2013	194
24115128	12504	Sutti S	Adaptive immune responses triggered by oxidative stress contribute to hepatic inflammation in NASH.	Hepatology	2014	28
24237701	12504	Cahenzli J	Intestinal microbial diversity during early-life colonization shapes long-term IgE levels.	Cell host and microbe	2013	57
24574499	12504	Woodworth JS	Protective CD4 T cells targeting cryptic epitopes of Mycobacterium tuberculosis resist infection-driven terminal differentiation.	Journal of immunology	2014	22
24679471	12504	Gold MJ	Group 2 innate lymphoid cells facilitate sensitization to local, but not systemic, TH2-inducing allergen exposures.	The Journal of allergy and clinical immunology	2014	29
26660519	12504	Niemann CU	Disruption of in vivo Chronic Lymphocytic Leukemia Tumor-Microenvironment Interactions by Ibrutinib--Findings from an Investigator-Initiated Phase II Study.	Clinical cancer research 	2016	13
16906150	12870	Shiva S	Ceruloplasmin is a NO oxidase and nitrite synthase that determines endocrine NO homeostasis.	Nature chemical biology	2006	77
23424051	12870	Ayton S	Ceruloplasmin dysfunction and therapeutic potential for Parkinson disease.	Annals of neurology	2013	29
15077108	12918	Qi Y	Adiponectin acts in the brain to decrease body weight.	Nature medicine	2004	132
17108082	12918	McGill BE	Enhanced anxiety and stress-induced corticosterone release are associated with increased Crh expression in a mouse model of Rett syndrome.	Proceedings of the National Academy of Sciences of the United States of America	2006	74
18566122	12918	Rice CJ	A novel mouse model for acute and long-lasting consequences of early life stress.	Endocrinology	2008	77
18768700	12918	Mueller BR	Sex-specific programming of offspring emotionality after stress early in pregnancy.	The Journal of neuroscience 	2008	236
22508464	12918	Bangasser DA	Increased vulnerability of the brain norepinephrine system of females to corticotropin-releasing factor overexpression.	Molecular psychiatry	2013	27
22992651	12918	Gafford GM	Cell-type specific deletion of GABA(A)Î±1 in corticotropin-releasing factor-containing neurons enhances anxiety and disrupts fear extinction.	Proceedings of the National Academy of Sciences of the United States of America	2012	31
16214080	12944	Marnell L	C-reactive protein: ligands, receptors and role in inflammation.	Clinical immunology	2005	85
20953198	12944	Igawa T	Antibody recycling by engineered pH-dependent antigen binding improves the duration of antigen neutralization.	Nature biotechnology	2010	57
10655104	12950	Calandra T	Protection from septic shock by neutralization of macrophage migration inhibitory factor.	Nature medicine	2000	155
10670840	12950	Remick DG	Comparison of the mortality and inflammatory response of two models of sepsis: lipopolysaccharide vs. cecal ligation and puncture.	Shock	2000	101
15489639	12950	Watanabe H	Innate immune response in Th1- and Th2-dominant mouse strains.	Shock	2004	72
17334244	12950	Pavlov VA	Selective alpha7-nicotinic acetylcholine receptor agonist GTS-21 improves survival in murine endotoxemia and severe sepsis.	Critical care medicine	2007	84
19325479	12950	Osuchowski MF	Stratification is the key: inflammatory biomarkers accurately direct immunomodulatory therapy in experimental sepsis.	Critical care medicine	2009	46
26053123	12950	Blaho VA	HDL-bound sphingosine-1-phosphate restrains lymphopoiesis and neuroinflammation.	Nature	2015	22
17030620	12981	Lai WS	Novel mRNA targets for tristetraprolin (TTP) identified by global analysis of stabilized transcripts in TTP-deficient fibroblasts.	Molecular and cellular biology	2006	111
24469827	12981	Bromfield JJ	Maternal tract factors contribute to paternal seminal fluid impact on metabolic phenotype in offspring.	Proceedings of the National Academy of Sciences of the United States of America	2014	40
25388222	12981	Huen SC	GM-CSF Promotes Macrophage Alternative Activation after Renal Ischemia/Reperfusion Injury.	Journal of the American Society of Nephrology 	2015	15
11812920	13106	Jaeschke H	Mechanisms of hepatotoxicity.	Toxicological sciences 	2002	183
19133650	13106	Roychowdhury S	An early complement-dependent and TLR-4-independent phase in the pathogenesis of ethanol-induced liver injury in mice.	Hepatology	2009	48
24064383	13106	Abdelmegeed MA	CYP2E1 potentiates binge alcohol-induced gut leakiness, steatohepatitis, and apoptosis.	Free radical biology and medicine	2013	37
11279518	13122	Shih DQ	Hepatocyte nuclear factor-1alpha is an essential regulator of bile acid and plasma cholesterol metabolism.	Nature genetics	2001	87
20623580	13122	Li T	Transgenic expression of cholesterol 7alpha-hydroxylase in the liver prevents high-fat diet-induced obesity and insulin resistance in mice.	Hepatology	2010	49
22144677	13122	Li T	Glucose and insulin induction of bile acid synthesis: mechanisms and implication in diabetes and obesity.	The Journal of biological chemistry	2012	40
9482784	13162	Jones SR	Mechanisms of amphetamine action revealed in mice lacking the dopamine transporter.	The Journal of neuroscience 	1998	127
9520487	13162	Jones SR	Profound neuronal plasticity in response to inactivation of the dopamine transporter.	Proceedings of the National Academy of Sciences of the United States of America	1998	134
9888856	13162	Gainetdinov RR	Role of serotonin in the paradoxical calming effect of psychostimulants on hyperactivity.	Science	1999	135
11172062	13162	Zhuang X	Hyperactivity and impaired response habituation in hyperdopaminergic mice.	Proceedings of the National Academy of Sciences of the United States of America	2001	124
11222668	13162	Wisor JP	Dopaminergic role in stimulant-induced wakefulness.	The Journal of neuroscience 	2001	129
11320258	13162	Sora I	Molecular mechanisms of cocaine reward: combined dopamine and serotonin transporter knockouts eliminate cocaine place preference.	Proceedings of the National Academy of Sciences of the United States of America	2001	94
11784783	13162	MorÃ³n JA	Dopamine uptake through the norepinephrine transporter in brain regions with low levels of the dopamine transporter: evidence from knock-out mouse lines.	The Journal of neuroscience 	2002	127
12359863	13162	Gainetdinov RR	Monoamine transporters: from genes to behavior.	Annual review of pharmacology and toxicology	2003	105
14561867	13162	PeciÃ±a S	Hyperdopaminergic mutant mice have higher "wanting" but not "liking" for sweet rewards.	The Journal of neuroscience 	2003	103
16515684	13162	Han DD	Comparison of the monoamine transporters from human and mouse in their sensitivities to psychostimulant drugs.	BMC pharmacology	2006	116
16754872	13162	Chen R	Abolished cocaine reward in mice with a cocaine-insensitive dopamine transporter.	Proceedings of the National Academy of Sciences of the United States of America	2006	98
16865686	13162	BÃ¤ckman CM	Characterization of a mouse strain expressing Cre recombinase from the 3' untranslated region of the dopamine transporter locus.	Genesis	2006	82
17380124	13162	Lee FJ	Dopamine transporter cell surface localization facilitated by a direct interaction with the dopamine D2 receptor.	The EMBO journal	2007	61
18347339	13162	Salahpour A	Increased amphetamine-induced hyperactivity and reward in mice overexpressing the dopamine transporter.	Proceedings of the National Academy of Sciences of the United States of America	2008	55
20685869	13162	Vucetic Z	Maternal high-fat diet alters methylation and gene expression of dopamine and opioid-related genes.	Endocrinology	2010	115
22712725	13162	Mebel DM	Insulin in the ventral tegmental area reduces hedonic feeding and suppresses dopamine concentration via increased reuptake.	The European journal of neuroscience	2012	31
24979798	13162	Ferris MJ	Dopamine transporters govern diurnal variation in extracellular dopamine tone.	Proceedings of the National Academy of Sciences of the United States of America	2014	23
25447236	13162	Masoud ST	Increased expression of the dopamine transporter leads to loss of dopamine neurons, oxidative stress and l-DOPA reversible motor deficits.	Neurobiology of disease	2015	15
26139373	13162	Banerjee A	An Interglomerular Circuit Gates Glomerular Output and Implements Gain Control in the Mouse Olfactory Bulb.	Neuron	2015	25
11095710	13405	Wang B	Adeno-associated virus vector carrying human minidystrophin genes effectively ameliorates muscular dystrophy in mdx mouse model.	Proceedings of the National Academy of Sciences of the United States of America	2000	103
12235126	13405	Vandebrouck C	Involvement of TRPC in the abnormal calcium influx observed in dystrophic (mdx) mouse skeletal muscle fibers.	The Journal of cell biology	2002	82
15608067	13405	Lu QL	Systemic delivery of antisense oligoribonucleotide restores dystrophin expression in body-wide skeletal muscles.	Proceedings of the National Academy of Sciences of the United States of America	2005	117
17162189	13405	Deconinck N	Pathophysiology of duchenne muscular dystrophy: current hypotheses.	Pediatric neurology	2007	105
17450125	13405	Welch EM	PTC124 targets genetic disorders caused by nonsense mutations.	Nature	2007	248
18545222	13405	Jearawiriyapaisarn N	Sustained dystrophin expression induced by peptide-conjugated morpholino oligomers in the muscles of mdx mice.	Molecular therapy 	2008	75
19238792	13405	Morcos PA	Vivo-Morpholinos: a non-peptide transporter delivers Morpholinos into a wide array of mouse tissues.	BioTechniques	2008	61
19759562	13405	Wu B	Dose-dependent restoration of dystrophin expression in cardiac muscle of dystrophic mice by systemically delivered morpholino.	Gene therapy	2010	44
21768542	13405	Rafael-Fortney JA	Early treatment with lisinopril and spironolactone preserves cardiac and skeletal muscle in Duchenne muscular dystrophy mice.	Circulation	2011	35
26237517	13405	Chal J	Differentiation of pluripotent stem cells to muscle fiber to model Duchenne muscular dystrophy.	Nature biotechnology	2015	34
16731832	13482	Mu J	Chronic inhibition of dipeptidyl peptidase-4 with a sitagliptin analog preserves pancreatic beta-cell mass and function in a rodent model of type 2 diabetes.	Diabetes	2006	97
21330637	13482	Shirakawa J	Diet-induced adipose tissue inflammation and liver steatosis are prevented by DPP-4 inhibition in diabetic mice.	Diabetes	2011	45
23270493	13482	Farag SS	In vivo DPP-4 inhibition to enhance engraftment of single-unit cord blood transplants in adults with hematological malignancies.	Stem cells and development	2013	27
14732717	13609	Sanna MG	Sphingosine 1-phosphate (S1P) receptor subtypes S1P1 and S1P3, respectively, regulate lymphocyte recirculation and heart rate.	The Journal of biological chemistry	2004	148
16403835	13609	Awad AS	Selective sphingosine 1-phosphate 1 receptor activation reduces ischemia-reperfusion injury in mouse kidney.	American journal of physiology. Renal physiology	2006	84
16936207	13609	Samad F	Altered adipose and plasma sphingolipid metabolism in obesity: a potential mechanism for cardiovascular and metabolic risk.	Diabetes	2006	66
17215483	13609	HÃ¤nel P	Erythrocytes store and release sphingosine 1-phosphate in blood.	FASEB journal 	2007	114
17363629	13609	Pappu R	Promotion of lymphocyte egress into blood and lymph by distinct sources of sphingosine-1-phosphate.	Science	2007	267
18258856	13609	Venkataraman K	Vascular endothelium as a contributor of plasma sphingosine 1-phosphate.	Circulation research	2008	137
19592277	13609	Weinreich MA	KLF2 transcription-factor deficiency in T cells results in unrestrained cytokine production and upregulation of bystander chemokine receptors.	Immunity	2009	79
20097939	13609	Bektas M	Sphingosine 1-phosphate lyase deficiency disrupts lipid homeostasis in liver.	The Journal of biological chemistry	2010	52
20407207	13609	Olivera A	Sphingosine kinase 1 and sphingosine-1-phosphate receptor 2 are vital to recovery from anaphylactic shock in mice.	The Journal of clinical investigation	2010	46
22884261	13609	Miller E	Identification of serum-derived sphingosine-1-phosphate as a small molecule regulator of YAP.	Chemistry and biology	2012	74
15994227	13850	Schmelzer KR	Soluble epoxide hydrolase is a therapeutic target for acute inflammation.	Proceedings of the National Academy of Sciences of the United States of America	2005	165
16857962	13850	Seubert JM	Role of soluble epoxide hydrolase in postischemic recovery of heart contractile function.	Circulation research	2006	78
17135253	13850	Luria A	Compensatory mechanism for homeostatic blood pressure regulation in Ephx2 gene-disrupted mice.	The Journal of biological chemistry	2007	62
17440491	13850	Zhang W	Soluble epoxide hydrolase: a novel therapeutic target in stroke.	Journal of cerebral blood flow and metabolism 	2007	85
18369166	13850	Zhang W	Soluble epoxide hydrolase gene deletion is protective against experimental cerebral ischemia.	Stroke	2008	73
21571638	13850	Luria A	Soluble epoxide hydrolase deficiency alters pancreatic islet size and improves glucose homeostasis in a model of insulin resistance.	Proceedings of the National Academy of Sciences of the United States of America	2011	48
12796124	13856	Cai Z	Hearts from rodents exposed to intermittent hypoxia or erythropoietin are protected against ischemia-reperfusion injury.	Circulation	2003	108
18334677	13856	Xing S	Transgenic expression of JAK2V617F causes myeloproliferative disorders in mice.	Blood	2008	73
20098432	13856	Li H	Transferrin therapy ameliorates disease in beta-thalassemic mice.	Nature medicine	2010	58
22334017	13856	KarikÃ³ K	Increased erythropoiesis in mice injected with submicrogram quantities of pseudouridine-containing mRNA encoding erythropoietin.	Molecular therapy 	2012	42
25193872	13856	Kautz L	Erythroferrone contributes to recovery from anemia of inflammation.	Blood	2014	20
11172057	13982	Dubal DB	Estrogen receptor alpha, not beta, is a critical link in estradiol-mediated protection against brain injury.	Proceedings of the National Academy of Sciences of the United States of America	2001	140
12351713	13982	Toran-Allerand CD	ER-X: a novel, plasma membrane-associated, putative estrogen receptor that is regulated during development and after ischemic brain injury.	The Journal of neuroscience 	2002	129
12588983	13982	Razandi M	Identification of a structural determinant necessary for the localization and function of estrogen receptor alpha at the plasma membrane.	Molecular and cellular biology	2003	87
12624116	13982	Couse JF	Characterization of the hypothalamic-pituitary-gonadal axis in estrogen receptor (ER) Null mice reveals hypergonadism and endocrine sex reversal in females lacking ERalpha but not ERbeta.	Molecular endocrinology	2003	79
15231873	13982	Razandi M	Plasma membrane estrogen receptors exist and functions as dimers.	Molecular endocrinology	2004	86
16463047	13982	Bryzgalova G	Evidence that oestrogen receptor-alpha plays an important role in the regulation of glucose homeostasis in mice: insulin sensitivity in the liver.	Diabetologia	2006	79
16645038	13982	Pedram A	Nature of functional estrogen receptors at the plasma membrane.	Molecular endocrinology	2006	150
17470805	13982	Glidewell-Kenney C	Nonclassical estrogen receptor alpha signaling mediates negative feedback in the female mouse reproductive axis.	Proceedings of the National Academy of Sciences of the United States of America	2007	57
17535799	13982	Pedram A	A conserved mechanism for steroid receptor translocation to the plasma membrane.	The Journal of biological chemistry	2007	137
19054762	13982	Pedram A	Developmental phenotype of a membrane only estrogen receptor alpha (MOER) mouse.	The Journal of biological chemistry	2009	46
21900603	13982	Ribas V	Myeloid-specific estrogen receptor alpha deficiency impairs metabolic homeostasis and accelerates atherosclerotic lesion development.	Proceedings of the National Academy of Sciences of the United States of America	2011	47
24038209	13982	Melville KM	Female mice lacking estrogen receptor-alpha in osteoblasts have compromised bone mass and strength.	Journal of bone and mineral research 	2014	22
24371309	13982	Adlanmerini M	Mutation of the palmitoylation site of estrogen receptor Î± in vivo reveals tissue-specific roles for membrane versus nuclear actions.	Proceedings of the National Academy of Sciences of the United States of America	2014	37
16102047	14061	Coughlin SR	Protease-activated receptors in hemostasis, thrombosis and vascular biology.	Journal of thrombosis and haemostasis 	2005	227
21711444	14061	Ammollo CT	Extracellular histones increase plasma thrombin generation by impairing thrombomodulin-dependent protein C activation.	Journal of thrombosis and haemostasis 	2011	45
21998060	14061	Zhou W	Hemostatic therapy in experimental intracerebral hemorrhage associated with the direct thrombin inhibitor dabigatran.	Stroke	2011	43
22707478	14061	Wolstenholme JT	Gestational exposure to bisphenol a produces transgenerational changes in behaviors and gene expression.	Endocrinology	2012	64
7647782	14069	Bi L	Targeted disruption of the mouse factor VIII gene produces a model of haemophilia A.	Nature genetics	1995	142
16522813	14069	Jiang H	Multiyear therapeutic benefit of AAV serotypes 2, 6, and 8 delivering factor VIII to hemophilia A mice and dogs.	Blood	2006	71
19139414	14069	Xu D	Phenotypic correction of murine hemophilia A using an iPS cell-based therapy.	Proceedings of the National Academy of Sciences of the United States of America	2009	80
24705491	14069	Fahs SA	A conditional knockout mouse model reveals endothelial cells as the principal and possibly exclusive source of plasma factor VIII.	Blood	2014	32
24719406	14069	Everett LA	Murine coagulation factor VIII is synthesized in endothelial cells.	Blood	2014	26
8833906	14104	Shimano H	Overproduction of cholesterol and fatty acids causes massive liver enlargement in transgenic mice expressing truncated SREBP-1a.	The Journal of clinical investigation	1996	185
12840063	14104	Xu A	The fat-derived hormone adiponectin alleviates alcoholic and nonalcoholic fatty liver diseases in mice.	The Journal of clinical investigation	2003	253
16054078	14104	Chakravarthy MV	"New" hepatic fat activates PPARalpha to maintain glucose, lipid, and cholesterol homeostasis.	Cell metabolism	2005	162
19724016	14104	Yamazaki Y	Treatment with SRT1720, a SIRT1 activator, ameliorates fatty liver with reduced expression of lipogenic enzymes in MSG mice.	American journal of physiology. Endocrinology and metabolism	2009	54
25038053	14104	Goedeke L	Long-term therapeutic silencing of miR-33 increases circulating triglyceride levels and hepatic lipid accumulation in mice.	EMBO molecular medicine	2014	31
11717196	14132	Ober RJ	Differences in promiscuity for antibody-FcRn interactions across species: implications for therapeutic antibodies.	International immunology	2001	106
12566415	14132	Chaudhury C	The major histocompatibility complex-related Fc receptor for IgG (FcRn) binds albumin and prolongs its lifespan.	The Journal of experimental medicine	2003	109
12646614	14132	Roopenian DC	The MHC class I-like IgG receptor controls perinatal IgG transport, IgG homeostasis, and fate of IgG-Fc-coupled drugs.	Journal of immunology	2003	122
16365427	14132	Hinton PR	An engineered human IgG1 antibody with longer serum half-life.	Journal of immunology	2006	66
17077181	14132	Petkova SB	Enhanced half-life of genetically engineered human IgG1 antibodies in a humanized FcRn mouse model: potential application in humorally mediated autoimmune disease.	International immunology	2006	84
17636457	14132	Garg A	Physiologically-based pharmacokinetic (PBPK) model to predict IgG tissue kinetics in wild-type and FcRn-knockout mice.	Journal of pharmacokinetics and pharmacodynamics	2007	61
17878355	14132	Akilesh S	Neonatal FcR expression in bone marrow-derived cells functions to protect serum IgG from catabolism.	Journal of immunology	2007	73
18198272	14132	Akilesh S	Podocytes use FcRn to clear IgG from the glomerular basement membrane.	Proceedings of the National Academy of Sciences of the United States of America	2008	70
20018855	14132	Andersen JT	Cross-species binding analyses of mouse and human neonatal Fc receptor show dramatic differences in immunoglobulin G and albumin binding.	The Journal of biological chemistry	2010	42
21368166	14132	Li Z	Transfer of IgG in the female genital tract by MHC class I-related neonatal Fc receptor (FcRn) confers protective immunity to vaginal infection.	Proceedings of the National Academy of Sciences of the United States of America	2011	56
22143261	14132	Shah DK	Towards a platform PBPK model to characterize the plasma and tissue disposition of monoclonal antibodies in preclinical species and human.	Journal of pharmacokinetics and pharmacodynamics	2012	40
9548730	14268	Zhong C	Rho-mediated contractility exposes a cryptic site in fibronectin and induces fibronectin matrix assembly.	The Journal of cell biology	1998	181
11566097	14268	Roberts M	PDGF-regulated rab4-dependent recycling of alphavbeta3 integrin from early endosomes is necessary for cell adhesion and spreading.	Current biology 	2001	120
15093739	14268	Tropel P	Isolation and characterisation of mesenchymal stem cells from adult mouse bone marrow.	Experimental cell research	2004	77
19407246	14268	Chiang HY	Fibronectin is an important regulator of flow-induced vascular remodeling.	Arteriosclerosis, thrombosis, and vascular biology	2009	49
21270273	14268	Kitada M	Resveratrol improves oxidative stress and protects against diabetic nephropathy through normalization of Mn-SOD dysfunction in AMPK/SIRT1-independent pathway.	Diabetes	2011	63
22354151	14268	del Zoppo GJ	Microglial cell activation is a source of metalloproteinase generation during hemorrhagic transformation.	Journal of cerebral blood flow and metabolism 	2012	33
17724330	14526	Jang HJ	Gut-expressed gustducin and taste receptors regulate secretion of glucagon-like peptide-1.	Proceedings of the National Academy of Sciences of the United States of America	2007	219
18519800	14526	Edfalk S	Gpr40 is expressed in enteroendocrine cells and mediates free fatty acid stimulation of incretin secretion.	Diabetes	2008	106
18796545	14526	Zhou J	Dietary resistant starch upregulates total GLP-1 and PYY in a sustained day-long manner through fermentation in rodents.	American journal of physiology. Endocrinology and metabolism	2008	75
19221011	14526	Ma J	Effect of the artificial sweetener, sucralose, on gastric emptying and incretin hormone release in healthy subjects.	American journal of physiology. Gastrointestinal and liver physiology	2009	55
21245306	14526	Janssen S	Bitter taste receptors and Î±-gustducin regulate the secretion of ghrelin with functional effects on food intake and gastric emptying.	Proceedings of the National Academy of Sciences of the United States of America	2011	60
22037645	14526	Ellingsgaard H	Interleukin-6 enhances insulin secretion by increasing glucagon-like peptide-1 secretion from L cells and alpha cells.	Nature medicine	2011	119
24237703	14526	Wichmann A	Microbial modulation of energy availability in the colon regulates intestinal transit.	Cell host and microbe	2013	41
25109781	14526	Psichas A	The short chain fatty acid propionate stimulates GLP-1 and PYY secretion via free fatty acid receptor 2 in rodents.	International journal of obesity	2015	33
25303528	14526	Yore MM	Discovery of a class of endogenous mammalian lipids with anti-diabetic and anti-inflammatory effects.	Cell	2014	58
25894829	14526	Bonner C	Inhibition of the glucose transporter SGLT2 with dapagliflozin in pancreatic alpha cells triggers glucagon secretion.	Nature medicine	2015	47
17131145	14527	Conarello SL	Glucagon receptor knockout mice are resistant to diet-induced obesity and streptozotocin-mediated beta cell loss and hyperglycaemia.	Diabetologia	2007	56
19046568	14527	Longuet C	The glucagon receptor is required for the adaptive metabolic response to fasting.	Cell metabolism	2008	52
19602537	14527	Pocai A	Glucagon-like peptide 1/glucagon receptor dual agonism reverses obesity in mice.	Diabetes	2009	48
22214853	14527	Unger RH	Glucagonocentric restructuring of diabetes: a pathophysiologic and therapeutic makeover.	The Journal of clinical investigation	2012	116
23305646	14527	Habegger KM	Fibroblast growth factor 21 mediates specific glucagon actions.	Diabetes	2013	26
25675519	14527	Wang MY	Glucagon receptor antibody completely suppresses type 1 diabetes phenotype without insulin by disrupting a novel diabetogenic pathway.	Proceedings of the National Academy of Sciences of the United States of America	2015	17
15536017	14599	Bartke A	Life extension in the dwarf mouse.	Current topics in developmental biology	2004	111
18346217	14599	Bartke A	Impact of reduced insulin-like growth factor-1/insulin signaling on aging in mammals: novel findings.	Aging cell	2008	56
24341939	14599	Gong Z	Reductions in serum IGF-1 during aging impair health span.	Aging cell	2014	21
15153518	15111	Bashir ME	Toll-like receptor 4 signaling by intestinal microbes influences susceptibility to food allergy.	Journal of immunology	2004	80
18641328	15111	Stummvoll GH	Th1, Th2, and Th17 effector T cell-induced autoimmune gastritis differs in pathological pattern and in susceptibility to suppression by regulatory T cells.	Journal of immunology	2008	53
18942757	15111	Alex P	Distinct cytokine patterns identified from multiplex profiles of murine DSS and TNBS-induced colitis.	Inflammatory bowel diseases	2009	160
22392053	15111	Milovanovic M	IL-33/ST2 axis in inflammation and immunopathology.	Immunologic research	2012	59
25145536	15111	Russell SL	Perinatal antibiotic-induced shifts in gut microbiota have differential effects on inflammatory lung diseases.	The Journal of allergy and clinical immunology	2015	21
25485616	15111	Kim J	Injectable, spontaneously assembling, inorganic scaffolds modulate immune cells in vivo and increase vaccine efficacy.	Nature biotechnology	2015	21
10699173	15194	Wheeler VC	Long glutamine tracts cause nuclear localization of a novel form of huntingtin in medium spiny striatal neurons in HdhQ92 and HdhQ111 knock-in mice.	Human molecular genetics	2000	113
14625137	15194	Holmes A	Abnormal behavioral phenotypes of serotonin transporter knockout mice: parallels with human anxiety and depression.	Biological psychiatry	2003	75
15163634	15194	Choo YS	Mutant huntingtin directly increases susceptibility of mitochondria to the calcium-induced permeability transition and cytochrome c release.	Human molecular genetics	2004	107
16365166	15194	Shin JY	Expression of mutant huntingtin in glial cells contributes to neuronal excitotoxicity.	The Journal of cell biology	2005	110
19525941	15194	Morfini GA	Pathogenic huntingtin inhibits fast axonal transport by activating JNK3 and phosphorylating kinesin.	Nature neuroscience	2009	83
19825844	15194	Sathasivam K	Identical oligomeric and fibrillar structures captured from the brains of R6/2 and knock-in mouse models of Huntington's disease.	Human molecular genetics	2010	65
20494921	15194	Faideau M	In vivo expression of polyglutamine-expanded huntingtin by mouse striatal astrocytes impairs glutamate transport: a correlation with Huntington's disease subjects.	Human molecular genetics	2010	56
23372043	15194	Hsiao HY	A critical role of astrocyte-mediated nuclear factor-ÎºB-dependent inflammation in Huntington's disease.	Human molecular genetics	2013	34
25038828	15194	FernÃ¡ndez-Nogales M	Huntington's disease is a four-repeat tauopathy with tau nuclear rods.	Nature medicine	2014	34
25556834	15194	Lee JH	Reinstating aberrant mTORC1 activity in Huntington's disease mice improves disease phenotypes.	Neuron	2015	16
14695889	15289	Yang H	Reversing established sepsis with antagonists of endogenous high-mobility group box 1.	Proceedings of the National Academy of Sciences of the United States of America	2004	292
15374839	15289	Ueno H	Contributions of high mobility group box protein in experimental and clinical acute lung injury.	American journal of respiratory and critical care medicine	2004	89
15640285	15289	Kim JY	HMGB1 contributes to the development of acute lung injury after hemorrhage.	American journal of physiology. Lung cellular and molecular physiology	2005	72
16953558	15289	Yang R	Anti-HMGB1 neutralizing antibody ameliorates gut barrier dysfunction and improves survival after hemorrhagic shock.	Molecular medicine	2006	86
17475888	15289	Fan J	Hemorrhagic shock induces NAD(P)H oxidase activation in neutrophils: role of HMGB1-TLR4 signaling.	Journal of immunology	2007	84
17652366	15289	Levy RM	Systemic inflammation and remote organ injury following trauma require HMGB1.	American journal of physiology. Regulatory, integrative and comparative physiology	2007	73
18768881	15289	Liu G	High mobility group protein-1 inhibits phagocytosis of apoptotic neutrophils through binding to phosphatidylserine.	Journal of immunology	2008	51
19783637	15289	Antoine DJ	High-mobility group box-1 protein and keratin-18, circulating serum proteins informative of acetaminophen-induced necrosis and apoptosis in vivo.	Toxicological sciences 	2009	65
19902481	15289	Bamboat ZM	Toll-like receptor 9 inhibition confers protection from liver ischemia-reperfusion injury.	Hepatology	2010	62
20811657	15289	Antoine DJ	Diet restriction inhibits apoptosis and HMGB1 oxidation and promotes inflammatory cell recruitment during acetaminophen hepatotoxicity.	Molecular medicine	2010	43
20847143	15289	Wu H	HMGB1 contributes to kidney ischemia reperfusion injury.	Journal of the American Society of Nephrology 	2010	77
22105604	15289	Yang H	Redox modification of cysteine residues regulates the cytokine activity of high mobility group box-1 (HMGB1).	Molecular medicine	2012	124
22634723	15289	Chavan SS	HMGB1 mediates cognitive impairment in sepsis survivors.	Molecular medicine	2012	35
22821628	15289	Wang X	High-mobility group box 1 (HMGB1)-Toll-like receptor (TLR)4-interleukin (IL)-23-IL-17A axis in drug-induced damage-associated lethal hepatitis: Interaction of Î³Î´ T cells with macrophages.	Hepatology	2013	35
24361123	15289	Kang R	Intracellular Hmgb1 inhibits inflammatory nucleosome release and limits acute pancreatitis in mice.	Gastroenterology	2014	43
24928512	15289	Ge X	High mobility group box-1 (HMGB1) participates in the pathogenesis of alcoholic liver disease (ALD).	The Journal of biological chemistry	2014	27
25562324	15289	Huebener P	The HMGB1/RAGE axis triggers neutrophil-mediated injury amplification following necrosis.	The Journal of clinical investigation	2015	48
26551681	15289	Vogel S	Platelet-derived HMGB1 is a critical mediator of thrombosis.	The Journal of clinical investigation	2015	15
9380735	15368	Poss KD	Heme oxygenase 1 is required for mammalian iron reutilization.	Proceedings of the National Academy of Sciences of the United States of America	1997	206
15331427	15368	Kapturczak MH	Heme oxygenase-1 modulates early inflammatory responses: evidence from the heme oxygenase-1-deficient mouse.	The American journal of pathology	2004	96
16485041	15368	Belcher JD	Heme oxygenase-1 is a modulator of inflammation and vaso-occlusion in transgenic sickle mice.	The Journal of clinical investigation	2006	78
20881280	15368	Larsen R	A central role for free heme in the pathogenesis of severe sepsis.	Science translational medicine	2010	107
22262768	15368	Fortes GB	Heme induces programmed necrosis on macrophages through autocrine TNF and ROS production.	Blood	2012	42
25593219	15368	Sun C	Sulforaphane alleviates muscular dystrophy in mdx mice by activation of Nrf2.	Journal of applied physiology	2015	18
25790743	15368	Sala E	Mesenchymal Stem Cells Reduce Colitis in Mice via Release of TSG6, Independently of Their Localization to the Intestine.	Gastroenterology	2015	21
9405715	15483	Kotelevtsev Y	11beta-hydroxysteroid dehydrogenase type 1 knockout mice show attenuated glucocorticoid-inducible responses and resist hyperglycemia on obesity or stress.	Proceedings of the National Academy of Sciences of the United States of America	1997	139
18086952	15483	Samuelsson AM	Diet-induced obesity in female mice leads to offspring hyperphagia, adiposity, hypertension, and insulin resistance: a novel murine model of developmental programming.	Hypertension	2008	195
9547354	15567	Bengel D	Altered brain serotonin homeostasis and locomotor insensitivity to 3, 4-methylenedioxymethamphetamine ("Ecstasy") in serotonin transporter-deficient mice.	Molecular pharmacology	1998	151
11487658	15567	Chen JJ	Maintenance of serotonin in the intestinal mucosa and ganglia of mice that lack the high-affinity serotonin transporter: Abnormal intestinal motility and the expression of cation transporters.	The Journal of neuroscience 	2001	87
14625138	15567	Lira A	Altered depression-related behaviors and functional changes in the dorsal raphe nucleus of serotonin transporter-deficient mice.	Biological psychiatry	2003	94
15087484	15567	Murphy DL	Serotonin transporter: gene, genetic disorders, and pharmacogenetics.	Molecular interventions	2004	79
15514160	15567	Ansorge MS	Early-life blockade of the 5-HT transporter alters emotional behavior in adult mice.	Science	2004	197
15589347	15567	Mathews TA	Gene dose-dependent alterations in extraneuronal serotonin but not dopamine in mice with reduced serotonin transporter expression.	Journal of neuroscience methods	2004	74
16452991	15567	Zhu CB	The proinflammatory cytokines interleukin-1beta and tumor necrosis factor-alpha activate serotonin transporters.	Neuropsychopharmacology 	2006	90
17234600	15567	Wellman CL	Impaired stress-coping and fear extinction and abnormal corticolimbic morphology in serotonin transporter knock-out mice.	The Journal of neuroscience 	2007	116
18209729	15567	Murphy DL	Targeting the murine serotonin transporter: insights into human neurobiology.	Nature reviews. Neuroscience	2008	116
18317590	15567	Carneiro AM	Interactions between integrin alphaIIbbeta3 and the serotonin transporter regulate serotonin transport and platelet aggregation in mice and humans.	The Journal of clinical investigation	2008	53
19208814	15567	Page DT	Haploinsufficiency for Pten and Serotonin transporter cooperatively influences brain size and social behavior.	Proceedings of the National Academy of Sciences of the United States of America	2009	49
19698744	15567	Kalueff AV	Conserved role for the serotonin transporter gene in rat and mouse neurobehavioral endophenotypes.	Neuroscience and biobehavioral reviews	2010	40
19963284	15567	Homberg JR	New perspectives on the neurodevelopmental effects of SSRIs.	Trends in pharmacological sciences	2010	53
20032063	15567	Brigman JL	Pharmacological or genetic inactivation of the serotonin transporter improves reversal learning in mice.	Cerebral cortex	2010	59
20827273	15567	Zhu CB	Interleukin-1 receptor activation by systemic lipopolysaccharide induces behavioral despair linked to MAPK regulation of CNS serotonin transporters.	Neuropsychopharmacology 	2010	49
20847275	15567	Baudry A	miR-16 targets the serotonin transporter: a new facet for adaptive responses to antidepressants.	Science	2010	101
21177701	15567	White K	The serotonin transporter, gender, and 17Î² oestradiol in the development of pulmonary arterial hypertension.	Cardiovascular research	2011	37
21677183	15567	Li Z	Essential roles of enteric neuronal serotonin in gastrointestinal motility and the development/survival of enteric dopaminergic neurons.	The Journal of neuroscience 	2011	73
23305936	15567	Couch Y	Microglial activation, increased TNF and SERT expression in the prefrontal cortex define stress-altered behaviour in mice susceptible to anhedonia.	Brain, behavior, and immunity	2013	27
26577932	15567	Muller CL	The serotonin system in autism spectrum disorder: From biomarker to animal models.	Neuroscience	2016	19
27111230	15567	Margolis KG	Serotonin transporter variant drives preventable gastrointestinal abnormalities in development and function.	The Journal of clinical investigation	2016	12
18195714	15930	O'Connor JC	Lipopolysaccharide-induced depressive-like behavior is mediated by indoleamine 2,3-dioxygenase activation in mice.	Molecular psychiatry	2009	208
19339614	15930	O'Connor JC	Interferon-gamma and tumor necrosis factor-alpha mediate the upregulation of indoleamine 2,3-dioxygenase and the induction of depressive-like behavior in mice in response to bacillus Calmette-Guerin.	The Journal of neuroscience 	2009	110
20124451	15930	Koblish HK	Hydroxyamidine inhibitors of indoleamine-2,3-dioxygenase potently suppress systemic tryptophan catabolism and the growth of IDO-expressing tumors.	Molecular cancer therapeutics	2010	40
20190767	15930	Wang Y	Kynurenine is an endothelium-derived relaxing factor produced during inflammation.	Nature medicine	2010	76
22355111	15930	Ravishankar B	Tolerance to apoptotic cells is regulated by indoleamine 2,3-dioxygenase.	Proceedings of the National Academy of Sciences of the United States of America	2012	41
24402311	15930	Metz R	IDO2 is critical for IDO1-mediated T-cell regulation and exerts a non-redundant function in inflammation.	International immunology	2014	31
2104918	15978	Sadick MD	Cure of murine leishmaniasis with anti-interleukin 4 monoclonal antibody. Evidence for a T cell-dependent, interferon gamma-independent mechanism.	The Journal of experimental medicine	1990	154
2521244	15978	Heinzel FP	Reciprocal expression of interferon gamma or interleukin 4 during the resolution or progression of murine leishmaniasis. Evidence for expansion of distinct helper T cell subsets.	The Journal of experimental medicine	1989	356
11830474	15978	Smyth MJ	Sequential production of interferon-gamma by NK1.1(+) T cells and natural killer cells is essential for the antimetastatic effect of alpha-galactosylceramide.	Blood	2002	104
12154358	15978	Fujii S	Prolonged IFN-gamma-producing NKT response induced with alpha-galactosylceramide-loaded DCs.	Nature immunology	2002	140
15069016	15978	Jordan MB	An animal model of hemophagocytic lymphohistiocytosis (HLH): CD8+ T cells and interferon gamma are essential for the disorder.	Blood	2004	102
16920924	15978	Brown DM	CD4 T cell-mediated protection from lethal influenza: perforin and antibody-mediated mechanisms give a one-two punch.	Journal of immunology	2006	127
17034586	15978	Ito R	Interferon-gamma is causatively involved in experimental inflammatory bowel disease in mice.	Clinical and experimental immunology	2006	67
17376993	15978	Mount MP	Involvement of interferon-gamma in microglial-mediated loss of dopaminergic neurons.	The Journal of neuroscience 	2007	59
17393408	15978	Young DA	Blockade of the interleukin-21/interleukin-21 receptor pathway ameliorates disease in animal models of rheumatoid arthritis.	Arthritis and rheumatism	2007	67
17579074	15978	Kirimanjeswara GS	Prophylactic and therapeutic use of antibodies for protection against respiratory infection with Francisella tularensis.	Journal of immunology	2007	60
18097058	15978	Niess JH	Commensal gut flora drives the expansion of proinflammatory CD4 T cells in the colonic lamina propria under normal and inflammatory conditions.	Journal of immunology	2008	56
18958172	15978	Croyle MA	Nasal delivery of an adenovirus-based vaccine bypasses pre-existing immunity to the vaccine carrier and improves the immune response in mice.	PloS one	2008	64
19633655	15978	Liu J	Genetic deficiency and pharmacological stabilization of mast cells reduce diet-induced obesity and diabetes in mice.	Nature medicine	2009	175
20126448	15978	Couper KN	Parasite-derived plasma microparticles contribute significantly to malaria infection-induced inflammation through potent macrophage stimulation.	PLoS pathogens	2010	48
7744859	16000	Coleman ME	Myogenic vector expression of insulin-like growth factor I stimulates muscle cell differentiation and myofiber hypertrophy in transgenic mice.	The Journal of biological chemistry	1995	117
10359843	16000	SjÃ¶gren K	Liver-derived insulin-like growth factor I (IGF-I) is the principal source of IGF-I in blood but is not required for postnatal body growth in mice.	Proceedings of the National Academy of Sciences of the United States of America	1999	118
12235108	16000	Yakar S	Circulating levels of IGF-1 directly regulate bone growth and density.	The Journal of clinical investigation	2002	177
12415260	16000	Carro E	Serum insulin-like growth factor I regulates brain amyloid-beta levels.	Nature medicine	2002	101
12610293	16000	Longo VD	Evolutionary medicine: from dwarf model systems to healthy centenarians?	Science	2003	154
14534077	16000	Barbieri M	Insulin/IGF-I-signaling pathway: an evolutionarily conserved mechanism of longevity from yeast to humans.	American journal of physiology. Endocrinology and metabolism	2003	105
15210967	16000	Lopez-Lopez C	Insulin-like growth factor I is required for vessel remodeling in the adult brain.	Proceedings of the National Academy of Sciences of the United States of America	2004	70
15924568	16000	Miller RA	Methionine-deficient diet extends mouse lifespan, slows immune and lens aging, alters glucose, T4, IGF-I and insulin levels, and increases hepatocyte MIF levels and stress resistance.	Aging cell	2005	168
18086533	16000	Trejo JL	The effects of exercise on spatial learning and anxiety-like behavior are mediated by an IGF-I-dependent mechanism related to hippocampal neurogenesis.	Molecular and cellular neurosciences	2008	61
19627267	16000	Yuan R	Aging in inbred strains of mice: study design and interim report on median lifespans and circulating IGF1 levels.	Aging cell	2009	113
19819967	16000	Dunn GA	Maternal high-fat diet promotes body length increases and insulin insensitivity in second-generation mice.	Endocrinology	2009	66
20229598	16000	Devlin MJ	Caloric restriction leads to high marrow adiposity and low bone mass in growing mice.	Journal of bone and mineral research 	2010	67
21386129	16000	Anisimov VN	If started early in life, metformin treatment increases life span and postpones tumors in female SHR mice.	Aging	2011	67
21520275	16000	Bartell SM	Central (ICV) leptin injection increases bone formation, bone mineral density, muscle mass, serum IGF-1, and the expression of osteogenic genes in leptin-deficient ob/ob mice.	Journal of bone and mineral research 	2011	44
23771523	16000	Quinn BJ	Inhibition of lung tumorigenesis by metformin is associated with decreased plasma IGF-I and diminished receptor tyrosine kinase signaling.	Cancer prevention research	2013	26
25619689	16000	Hofmann JW	Reduced expression of MYC increases longevity and enhances healthspan.	Cell	2015	30
26290229	16000	Gontier G	Blocking IGF Signaling in Adult Neurons Alleviates Alzheimer's Disease Pathology through Amyloid-Î² Clearance.	The Journal of neuroscience 	2015	17
9892616	16153	Bozza M	Targeted disruption of migration inhibitory factor gene reveals its critical role in sepsis.	The Journal of experimental medicine	1999	137
10843696	16153	Hoffmann KF	IL-10 and the dangers of immune polarization: excessive type 1 and type 2 cytokine responses induce distinct forms of lethal immunopathology in murine schistosomiasis.	Journal of immunology	2000	111
12642601	16153	Chiaramonte MG	Regulation and function of the interleukin 13 receptor alpha 2 during a T helper cell type 2-dominant immune response.	The Journal of experimental medicine	2003	86
14625346	16153	James LP	Acetaminophen-induced hepatotoxicity.	Drug metabolism and disposition	2003	131
16849510	16153	Osuchowski MF	Circulating cytokine/inhibitor profiles reshape the understanding of the SIRS/CARS continuum in sepsis and predict mortality.	Journal of immunology	2006	143
17030951	16153	Ejrnaes M	Resolution of a chronic viral infection after interleukin-10 receptor blockade.	The Journal of experimental medicine	2006	195
17641052	16153	Gupta N	Intrapulmonary delivery of bone marrow-derived mesenchymal stem cells improves survival and attenuates endotoxin-induced acute lung injury in mice.	Journal of immunology	2007	243
18348728	16153	Qin L	Increased systemic and brain cytokine production and neuroinflammation by endotoxin following ethanol treatment.	Journal of neuroinflammation	2008	128
19139201	16153	Deshmukh HS	Critical role of NOD2 in regulating the immune response to Staphylococcus aureus.	Infection and immunity	2009	47
19190234	16153	Lancel S	Carbon monoxide rescues mice from lethal sepsis by supporting mitochondrial energetic metabolism and activating mitochondrial biogenesis.	The Journal of pharmacology and experimental therapeutics	2009	49
19486646	16153	Jaeger LB	Lipopolysaccharide alters the blood-brain barrier transport of amyloid beta protein: a mechanism for inflammation in the progression of Alzheimer's disease.	Brain, behavior, and immunity	2009	51
19620304	16153	Madan R	Nonredundant roles for B cell-derived IL-10 in immune counter-regulation.	Journal of immunology	2009	102
20006839	16153	Perona-Wright G	Systemic but not local infections elicit immunosuppressive IL-10 production by natural killer cells.	Cell host and microbe	2009	54
20093775	16153	Bamboat ZM	Conventional DCs reduce liver ischemia/reperfusion injury in mice via IL-10 secretion.	The Journal of clinical investigation	2010	62
20368175	16153	CastaÃ±o AP	Serum amyloid P inhibits fibrosis through Fc gamma R-dependent monocyte-macrophage regulation in vivo.	Science translational medicine	2009	63
20518032	16153	Redford PS	Enhanced protection to Mycobacterium tuberculosis infection in IL-10-deficient mice is accompanied by early and enhanced Th1 responses in the lung.	European journal of immunology	2010	72
20558630	16153	Mei SH	Mesenchymal stem cells reduce inflammation while enhancing bacterial clearance and improving survival in sepsis.	American journal of respiratory and critical care medicine	2010	135
20842630	16153	Ki SH	Interleukin-22 treatment ameliorates alcoholic liver injury in a murine model of chronic-binge ethanol feeding: role of signal transducer and activator of transcription 3.	Hepatology	2010	105
21433043	16153	Thomas JA	Macrophage therapy for murine liver fibrosis recruits host effector cells improving fibrosis, regeneration, and function.	Hepatology	2011	58
22114895	16153	DÃ©nes A	Systemic inflammatory challenges compromise survival after experimental stroke via augmenting brain inflammation, blood- brain barrier damage and brain oedema independently of infarct size.	Journal of neuroinflammation	2011	40
22198952	16153	Maseda D	Regulatory B10 cells differentiate into antibody-secreting cells after transient IL-10 production in vivo.	Journal of immunology	2012	42
22221071	16153	Tokuda K	Inhaled hydrogen sulfide prevents endotoxin-induced systemic inflammation and improves survival by altering sulfide metabolism in mice.	Antioxidants and redox signaling	2012	40
24572363	16153	Shen P	IL-35-producing B cells are critical regulators of immunity during autoimmune and infectious diseases.	Nature	2014	133
24959425	16153	Heimesaat MM	The role of serine protease HtrA in acute ulcerative enterocolitis and extra-intestinal immune responses during Campylobacter jejuni infection of gnotobiotic IL-10 deficient mice.	Frontiers in cellular and infection microbiology	2014	20
26446957	16153	Zhang J	ST2 blockade reduces sST2-producing T cells while maintaining protective mST2-expressing T cells during graft-versus-host disease.	Science translational medicine	2015	21
11067941	16171	Witowski J	IL-17 stimulates intraperitoneal neutrophil infiltration through the release of GRO alpha chemokine from mesothelial cells.	Journal of immunology	2000	99
12495931	16171	Hellings PW	Interleukin-17 orchestrates the granulocyte influx into airways after allergen inhalation in a mouse model of allergic asthma.	American journal of respiratory cell and molecular biology	2003	102
18299333	16171	Flierl MA	Adverse functions of IL-17A in experimental sepsis.	FASEB journal 	2008	75
18796297	16171	Ito R	Involvement of IL-17A in the pathogenesis of DSS-induced colitis in mice.	Biochemical and biophysical research communications	2008	55
19741298	16171	Charles KA	The tumor-promoting actions of TNF-alpha involve TNFR1 and IL-17 in ovarian cancer in mice and humans.	The Journal of clinical investigation	2009	88
20038749	16171	Madhur MS	Interleukin 17 promotes angiotensin II-induced hypertension and vascular dysfunction.	Hypertension	2010	138
20935201	16171	Chen S	IL-17A is proatherogenic in high-fat diet-induced and Chlamydia pneumoniae infection-accelerated atherosclerosis in mice.	Journal of immunology	2010	45
21297073	16171	Besnard AG	Dual Role of IL-22 in allergic airway inflammation and its cross-talk with IL-17A.	American journal of respiratory and critical care medicine	2011	43
21321928	16171	BlÃ¼ml S	Essential role of microRNA-155 in the pathogenesis of autoimmune arthritis in mice.	Arthritis and rheumatism	2011	55
21521466	16171	Fan L	Neutralizing IL-17 prevents obliterative bronchiolitis in murine orthotopic lung transplantation.	American journal of transplantation 	2011	51
21985374	16171	Tang Y	Interleukin-17 exacerbates hepatic steatosis and inflammation in non-alcoholic fatty liver disease.	Clinical and experimental immunology	2011	43
22025253	16171	Li C	IL-17 response mediates acute lung injury induced by the 2009 pandemic influenza A (H1N1) virus.	Cell research	2012	32
23671588	16171	Katayama M	Neutrophils are essential as a source of IL-17 in the effector phase of arthritis.	PloS one	2013	26
24614654	16171	Montgomery CP	Protective immunity against recurrent Staphylococcus aureus skin infection requires antibody and interleukin-17A.	Infection and immunity	2014	27
24747744	16171	Deshmukh HS	The microbiota regulates neutrophil homeostasis and host resistance to Escherichia coli K1 sepsis in neonatal mice.	Nature medicine	2014	65
25446779	16171	Pascual M	Cytokines and chemokines as biomarkers of ethanol-induced neuroinflammation and anxiety-related behavior: role of TLR4 and TLR2.	Neuropharmacology	2015	20
26411290	16171	Sano T	An IL-23R/IL-22 Circuit Regulates Epithelial Serum Amyloid A to Promote Local Effector Th17 Responses.	Cell	2015	41
16207887	16176	Cunningham C	Central and systemic endotoxin challenges exacerbate the local inflammatory response and increase neuronal death during chronic neurodegeneration.	The Journal of neuroscience 	2005	171
17325656	16176	Lin HS	Anti-rheumatic activities of histone deacetylase (HDAC) inhibitors in vivo in collagen-induced arthritis in rodents.	British journal of pharmacology	2007	58
17471177	16176	Donnelly-Roberts DL	Discovery of P2X7 receptor-selective antagonists offers new insights into P2X7 receptor function and indicates a role in chronic pain states.	British journal of pharmacology	2007	69
18417733	16176	Begum AN	Curcumin structure-function, bioavailability, and efficacy in models of neuroinflammation and Alzheimer's disease.	The Journal of pharmacology and experimental therapeutics	2008	92
18802069	16176	Sinha P	Proinflammatory S100 proteins regulate the accumulation of myeloid-derived suppressor cells.	Journal of immunology	2008	180
18931327	16176	Churg A	The role of interleukin-1beta in murine cigarette smoke-induced emphysema and small airway remodeling.	American journal of respiratory cell and molecular biology	2009	51
20818791	16176	Cibelli M	Role of interleukin-1beta in postoperative cognitive dysfunction.	Annals of neurology	2010	125
21543214	16176	Ashino NG	Maternal high-fat feeding through pregnancy and lactation predisposes mouse offspring to molecular insulin resistance and fatty liver.	The Journal of nutritional biochemistry	2012	31
22738332	16176	PÃ¼ntener U	Long-term impact of systemic bacterial infection on the cerebral vasculature and microglia.	Journal of neuroinflammation	2012	35
22848083	16176	Bracey NA	The Nlrp3 inflammasome promotes myocardial dysfunction in structural cardiomyopathy through interleukin-1Î².	Experimental physiology	2013	29
23203659	16176	Lewis JS Jr	Genetic and cellular evidence of decreased inflammation associated with reduced incidence of posttraumatic arthritis in MRL/MpJ mice.	Arthritis and rheumatism	2013	29
23225887	16176	He Y	TLR agonists stimulate Nlrp3-dependent IL-1Î² production independently of the purinergic P2X7 receptor in dendritic cells and in vivo.	Journal of immunology	2013	42
23361394	16176	Sudduth TL	Induction of hyperhomocysteinemia models vascular dementia by induction of cerebral microhemorrhages and neuroinflammation.	Journal of cerebral blood flow and metabolism 	2013	27
23840908	16176	Skelly DT	A systematic analysis of the peripheral and CNS effects of systemic LPS, IL-1Î², corrected TNF-Î± and IL-6 challenges in C57BL/6 mice.	PloS one	2013	33
25232870	16176	Brown AO	Streptococcus pneumoniae translocates into the myocardium and forms unique microlesions that disrupt cardiac function.	PLoS pathogens	2014	25
25626736	16176	Finucane OM	Monounsaturated fatty acid-enriched high-fat diets impede adipose NLRP3 inflammasome-mediated IL-1Î² secretion and insulin resistance despite obesity.	Diabetes	2015	22
25646681	16176	Wang X	Use of a pro-fibrogenic mechanism-based predictive toxicological approach for tiered testing and decision analysis of carbonaceous nanomaterials.	ACS nano	2015	22
26764184	16176	Hirsova P	Lipid-Induced Signaling Causes Release of Inflammatory Extracellular Vesicles From Hepatocytes.	Gastroenterology	2016	21
28092375	16176	Dror E	Postprandial macrophage-derived IL-1Î² stimulates insulin, and both synergistically promote glucose disposal and inflammation.	Nature immunology	2017	5
10361100	16193	Aoki Y	Angiogenesis and hematopoiesis induced by Kaposi's sarcoma-associated herpesvirus-encoded interleukin-6.	Blood	1999	96
12069181	16193	Remick DG	Six at six: interleukin-6 measured 6 h after the initiation of sepsis predicts mortality over 3 days.	Shock	2002	122
15561971	16193	Day YJ	Renal ischemia-reperfusion injury and adenosine 2A receptor-mediated tissue protection: role of macrophages.	American journal of physiology. Renal physiology	2005	91
15642986	16193	Copeland S	Acute inflammatory response to endotoxin in mice and humans.	Clinical and diagnostic laboratory immunology	2005	78
15863613	16193	Liuzzi JP	Interleukin-6 regulates the zinc transporter Zip14 in liver and contributes to the hypozincemia of the acute-phase response.	Proceedings of the National Academy of Sciences of the United States of America	2005	118
16192425	16193	Kielar ML	Maladaptive role of IL-6 in ischemic acute renal failure.	Journal of the American Society of Nephrology 	2005	78
16284237	16193	Lee DL	Angiotensin II hypertension is attenuated in interleukin-6 knockout mice.	American journal of physiology. Heart and circulatory physiology	2006	76
16581004	16193	Inoue H	Role of hepatic STAT3 in brain-insulin action on hepatic glucose production.	Cell metabolism	2006	88
17050710	16193	Sparkman NL	Interleukin-6 facilitates lipopolysaccharide-induced disruption in working memory and expression of other proinflammatory cytokines in hippocampal neuronal cell layers.	The Journal of neuroscience 	2006	90
17615358	16193	Naugler WE	Gender disparity in liver cancer due to sex differences in MyD88-dependent IL-6 production.	Science	2007	459
17885684	16193	Mutlu GM	Ambient particulate matter accelerates coagulation via an IL-6-dependent pathway.	The Journal of clinical investigation	2007	72
18337485	16193	Nechemia-Arbely Y	IL-6/IL-6R axis plays a critical role in acute kidney injury.	Journal of the American Society of Nephrology 	2008	55
18490655	16193	Jang S	Luteolin reduces IL-6 production in microglia by inhibiting JNK phosphorylation and activation of AP-1.	Proceedings of the National Academy of Sciences of the United States of America	2008	53
18510618	16193	Wieckowska A	Increased hepatic and circulating interleukin-6 levels in human nonalcoholic steatohepatitis.	The American journal of gastroenterology	2008	102
18596724	16193	Klein CL	Interleukin-6 mediates lung injury following ischemic acute kidney injury or bilateral nephrectomy.	Kidney international	2008	63
19284588	16193	Beurel E	Lipopolysaccharide-induced interleukin-6 production is controlled by glycogen synthase kinase-3 and STAT3 in the brain.	Journal of neuroinflammation	2009	48
19883714	16193	Lambert JD	Hepatotoxicity of high oral dose (-)-epigallocatechin-3-gallate in mice.	Food and chemical toxicology 	2010	55
19955044	16193	Cash H	Interleukin 6 (IL-6) deficiency delays lupus nephritis in MRL-Faslpr mice: the IL-6 pathway as a new therapeutic target in treatment of autoimmune kidney disease in systemic lupus erythematosus.	The Journal of rheumatology	2010	41
20956499	16193	Rytka JM	The portal theory supported by venous drainage-selective fat transplantation.	Diabetes	2011	40
21106853	16193	Fujimoto M	The influence of excessive IL-6 production in vivo on the development and function of Foxp3+ regulatory T cells.	Journal of immunology	2011	42
21217761	16193	Chu VT	Eosinophils are required for the maintenance of plasma cells in the bone marrow.	Nature immunology	2011	114
21423809	16193	Eto D	IL-21 and IL-6 are critical for different aspects of B cell immunity and redundantly induce optimal follicular helper CD4 T cell (Tfh) differentiation.	PloS one	2011	136
21697358	16193	Monje FJ	Constant darkness induces IL-6-dependent depression-like behavior through the NF-ÎºB signaling pathway.	The Journal of neuroscience 	2011	38
22075248	16193	Schuett H	Transsignaling of interleukin-6 crucially contributes to atherosclerosis in mice.	Arteriosclerosis, thrombosis, and vascular biology	2012	33
22335738	16193	Stone RL	Paraneoplastic thrombocytosis in ovarian cancer.	The New England journal of medicine	2012	114
22488116	16193	Samson M	Brief report: inhibition of interleukin-6 function corrects Th17/Treg cell imbalance in patients with rheumatoid arthritis.	Arthritis and rheumatism	2012	50
22835277	16193	Meng W	Depletion of neutrophil extracellular traps in vivo results in hypersusceptibility to polymicrobial sepsis in mice.	Critical care	2012	31
22841997	16193	Hanke ML	Beta adrenergic blockade decreases the immunomodulatory effects of social disruption stress.	Brain, behavior, and immunity	2012	39
23222255	16193	Iskander KN	Cecal ligation and puncture-induced murine sepsis does not cause lung injury.	Critical care medicine	2013	27
23426178	16193	Zhang H	IL-6 trans-signaling promotes pancreatitis-associated lung injury and lethality.	The Journal of clinical investigation	2013	32
24416310	16193	Knudsen JG	Role of IL-6 in exercise training- and cold-induced UCP1 expression in subcutaneous white adipose tissue.	PloS one	2014	22
25331895	16193	Hodes GE	Individual differences in the peripheral immune system promote resilience versus susceptibility to social stress.	Proceedings of the National Academy of Sciences of the United States of America	2014	63
25564572	16193	Chang TS	Activation of IL6/IGFIR confers poor prognosis of HBV-related hepatocellular carcinoma through induction of OCT4/NANOG expression.	Clinical cancer research 	2015	22
27679493	16193	Li M	MicroRNA-223 ameliorates alcoholic liver injury by inhibiting the IL-6-p47&lt;sup&gt;phox&lt;/sup&gt;-oxidative stress pathway in neutrophils.	Gut	2017	10
9844629	16337	BrÃ¼ning JC	A muscle-specific insulin receptor knockout exhibits features of the metabolic syndrome of NIDDM without altering glucose tolerance.	Molecular cell	1998	299
11000114	16337	BrÃ¼ning JC	Role of brain insulin receptor in control of body weight and reproduction.	Science	2000	382
12110165	16337	BlÃ¼her M	Adipose tissue selective insulin receptor knockout protects against obesity and obesity-related glucose intolerance.	Developmental cell	2002	182
17517043	16337	DrÃ¶ge W	Oxidative stress and aberrant signaling in aging and cognitive decline.	Aging cell	2007	102
20407209	16337	Shimizu I	Excessive cardiac insulin signaling exacerbates systolic dysfunction induced by pressure overload in rodents.	The Journal of clinical investigation	2010	48
25417115	16337	Gusarova V	ANGPTL8/betatrophin does not control pancreatic beta cell expansion.	Cell	2014	44
14528024	16591	Tsujikawa H	Klotho, a gene related to a syndrome resembling human premature aging, functions in a negative regulatory circuit of vitamin D endocrine system.	Molecular endocrinology	2003	114
15665504	16591	Li SA	Immunohistochemical localization of Klotho protein in brain, kidney, and reproductive organs of mice.	Cell structure and function	2004	78
17569864	16591	Imura A	alpha-Klotho as a regulator of calcium homeostasis.	Science	2007	89
18606998	16591	Cha SK	Removal of sialic acid involving Klotho causes cell-surface retention of TRPV5 channel via binding to galectin-1.	Proceedings of the National Academy of Sciences of the United States of America	2008	121
18835926	16591	Nakatani T	In vivo genetic evidence for klotho-dependent, fibroblast growth factor 23 (Fgf23) -mediated regulation of systemic phosphate homeostasis.	FASEB journal 	2009	79
19225558	16591	Ohnishi M	Reversal of mineral ion homeostasis and soft-tissue calcification of klotho knockout mice by deletion of vitamin D 1alpha-hydroxylase.	Kidney international	2009	60
19635988	16591	Wang Y	Klotho gene delivery prevents the progression of spontaneous hypertension and renal damage.	Hypertension	2009	57
20418498	16591	Ohnishi M	Dietary and genetic evidence for phosphate toxicity accelerating mammalian aging.	FASEB journal 	2010	51
20861825	16591	Hu MC	Klotho deficiency is an early biomarker of renal ischemia-reperfusion injury and its replacement is protective.	Kidney international	2010	68
21115613	16591	Hu MC	Klotho deficiency causes vascular calcification in chronic kidney disease.	Journal of the American Society of Nephrology 	2011	184
21719790	16591	Moreno JA	The inflammatory cytokines TWEAK and TNFÎ± reduce renal klotho expression through NFÎºB.	Journal of the American Society of Nephrology 	2011	53
24304882	16591	Panesso MC	Klotho has dual protective effects on cisplatin-induced acute kidney injury.	Kidney international	2014	24
24854271	16591	Lindberg K	The kidney is the principal organ mediating klotho effects.	Journal of the American Society of Nephrology 	2014	33
25326585	16591	Hu MC	Klotho and phosphate are modulators of pathologic uremic cardiac remodeling.	Journal of the American Society of Nephrology 	2015	31
25475745	16591	Xie J	Soluble Klotho Protects against Uremic Cardiomyopathy Independently of Fibroblast Growth Factor 23 and Phosphate.	Journal of the American Society of Nephrology 	2015	18
8182121	16835	Ishibashi S	Massive xanthomatosis and atherosclerosis in cholesterol-fed low density lipoprotein receptor-negative mice.	The Journal of clinical investigation	1994	135
8349823	16835	Ishibashi S	Hypercholesterolemia in low density lipoprotein receptor knockout mice and its reversal by adenovirus-mediated gene delivery.	The Journal of clinical investigation	1993	333
9734366	16835	Gu L	Absence of monocyte chemoattractant protein-1 reduces atherosclerosis in low density lipoprotein receptor-deficient mice.	Molecular cell	1998	269
12032330	16835	Joseph SB	Synthetic LXR ligand inhibits the development of atherosclerosis in mice.	Proceedings of the National Academy of Sciences of the United States of America	2002	187
12740573	16835	Binder CJ	Pneumococcal vaccination decreases atherosclerotic lesion formation: molecular mimicry between Streptococcus pneumoniae and oxidized LDL.	Nature medicine	2003	165
17932314	16835	Al-Aly Z	Aortic Msx2-Wnt calcification cascade is regulated by TNF-alpha-dependent signals in diabetic Ldlr-/- mice.	Arteriosclerosis, thrombosis, and vascular biology	2007	88
18239153	16835	Subramanian S	Dietary cholesterol worsens adipose tissue macrophage accumulation and atherosclerosis in obese LDL receptor-deficient mice.	Arteriosclerosis, thrombosis, and vascular biology	2008	62
18666236	16835	Wouters K	Dietary cholesterol, rather than liver steatosis, leads to hepatic inflammation in hyperlipidemic mouse models of nonalcoholic steatohepatitis.	Hepatology	2008	118
19478200	16835	Verschuren L	MIF deficiency reduces chronic inflammation in white adipose tissue and impairs the development of insulin resistance, glucose intolerance, and associated atherosclerotic disease.	Circulation research	2009	46
19520913	16835	Zelcer N	LXR regulates cholesterol uptake through Idol-dependent ubiquitination of the LDL receptor.	Science	2009	189
20816088	16835	Kjolby M	Sort1, encoded by the cardiovascular risk locus 1p13.3, is a regulator of hepatic lipoprotein export.	Cell metabolism	2010	57
21690490	16835	Maganto-GarcÃ­a E	Dynamic changes in regulatory T cells are linked to levels of diet-induced hypercholesterolemia.	Circulation	2011	38
22214850	16835	Owens AP 3rd	Monocyte tissue factor-dependent activation of coagulation in hypercholesterolemic mice and monkeys is inhibited by simvastatin.	The Journal of clinical investigation	2012	42
22223731	16835	Derwall M	Inhibition of bone morphogenetic protein signaling reduces vascular calcification and atherosclerosis.	Arteriosclerosis, thrombosis, and vascular biology	2012	47
22927427	16835	Castellano JM	Low-density lipoprotein receptor overexpression enhances the rate of brain-to-blood AÎ² clearance in a mouse model of Î²-amyloidosis.	Proceedings of the National Academy of Sciences of the United States of America	2012	40
23288159	16835	Marquart TJ	Anti-miR-33 therapy does not alter the progression of atherosclerosis in low-density lipoprotein receptor-deficient mice.	Arteriosclerosis, thrombosis, and vascular biology	2013	46
23426179	16835	Klingenberg R	Depletion of FOXP3+ regulatory T cells promotes hypercholesterolemia and atherosclerosis.	The Journal of clinical investigation	2013	61
23702658	16835	Rotllan N	Therapeutic silencing of microRNA-33 inhibits the progression of atherosclerosis in Ldlr-/- mice--brief report.	Arteriosclerosis, thrombosis, and vascular biology	2013	45
26437365	16835	Goedeke L	MicroRNA-148a regulates LDL receptor and ABCA1 expression to control circulating lipoprotein levels.	Nature medicine	2015	22
7584987	16846	Maffei M	Leptin levels in human and rodent: measurement of plasma leptin and ob RNA in obese and weight-reduced subjects.	Nature medicine	1995	442
7624776	16846	Pelleymounter MA	Effects of the obese gene product on body weight regulation in ob/ob mice.	Science	1995	531
9218503	16846	Haynes WG	Receptor-mediated regional sympathetic nerve activation by leptin.	The Journal of clinical investigation	1997	135
9238071	16846	Halaas JL	Physiological response to long-term peripheral and central leptin infusion in lean and obese mice.	Proceedings of the National Academy of Sciences of the United States of America	1997	155
9311777	16846	Kamohara S	Acute stimulation of glucose metabolism in mice by leptin treatment.	Nature	1997	110
10849588	16846	Lin S	Development of high fat diet-induced obesity and leptin resistance in C57Bl/6J mice.	International journal of obesity and related metabolic disorders 	2000	109
11937559	16846	Mancuso P	Leptin-deficient mice exhibit impaired host defense in Gram-negative pneumonia.	Journal of immunology	2002	89
12618528	16846	Matsusue K	Liver-specific disruption of PPARgamma in leptin-deficient mice improves fatty liver but aggravates diabetic phenotypes.	The Journal of clinical investigation	2003	130
16123334	16846	Li J	Intermittent hypoxia induces hyperlipidemia in lean mice.	Circulation research	2005	88
16580676	16846	Beltowski J	Leptin and atherosclerosis.	Atherosclerosis	2006	78
19190071	16846	Friedman JM	Leptin at 14 y of age: an ongoing story.	The American journal of clinical nutrition	2009	85
20308782	16846	Greco SJ	Leptin reduces pathology and improves memory in a transgenic mouse model of Alzheimer's disease.	Journal of Alzheimer's disease 	2010	56
20613882	16846	Knight ZA	Hyperleptinemia is required for the development of leptin resistance.	PloS one	2010	51
20929977	16846	Li L	Mitochondrial biogenesis and peroxisome proliferator-activated receptor-Î³ coactivator-1Î± (PGC-1Î±) deacetylation by physical activity: intact adipocytokine signaling is required.	Diabetes	2011	38
21406387	16846	Endo H	Leptin acts as a growth factor for colorectal tumours at stages subsequent to tumour initiation in murine colon carcinogenesis.	Gut	2011	43
22081158	16846	Domingos AI	Leptin regulates the reward value of nutrient.	Nature neuroscience	2011	58
22844426	16846	Gauffin Cano P	Bacteroides uniformis CECT 7771 ameliorates metabolic and immunological dysfunction in mice with high-fat-diet induced obesity.	PloS one	2012	38
23618531	16846	Wahlang B	Polychlorinated biphenyl 153 is a diet-dependent obesogen that worsens nonalcoholic fatty liver disease in male C57BL6/J mice.	The Journal of nutritional biochemistry	2013	29
12569168	16956	Yagyu H	Lipoprotein lipase (LpL) on the surface of cardiomyocytes increases lipid uptake and produces a cardiomyopathy.	The Journal of clinical investigation	2003	97
15995182	16956	Millar JS	Determining hepatic triglyceride production in mice: comparison of poloxamer 407 with Triton WR-1339.	Journal of lipid research	2005	79
20620994	16956	Davies BS	GPIHBP1 is responsible for the entry of lipoprotein lipase into capillaries.	Cell metabolism	2010	85
9108099	18669	Schinkel AH	Normal viability and altered pharmacokinetics in mice lacking mdr1-type (drug-transporting) P-glycoproteins.	Proceedings of the National Academy of Sciences of the United States of America	1997	118
20304939	18669	Kodaira H	Kinetic analysis of the cooperation of P-glycoprotein (P-gp/Abcb1) and breast cancer resistance protein (Bcrp/Abcg2) in limiting the brain and testis penetration of erlotinib, flavopiridol, and mitoxantrone.	The Journal of pharmacology and experimental therapeutics	2010	53
20421331	18669	Agarwal S	Distribution of gefitinib to the brain is limited by P-glycoprotein (ABCB1) and breast cancer resistance protein (ABCG2)-mediated active efflux.	The Journal of pharmacology and experimental therapeutics	2010	49
21351087	18669	Tang SC	Brain accumulation of sunitinib is restricted by P-glycoprotein (ABCB1) and breast cancer resistance protein (ABCG2) and can be enhanced by oral elacridar and sunitinib coadministration.	International journal of cancer	2012	36
9435299	18671	Kim RB	The drug transporter P-glycoprotein limits oral absorption and brain entry of HIV-1 protease inhibitors.	The Journal of clinical investigation	1998	138
19056914	18671	Polli JW	An unexpected synergist role of P-glycoprotein and breast cancer resistance protein on the central nervous system penetration of the tyrosine kinase inhibitor lapatinib (N-{3-chloro-4-(3-fluorobenzyl)oxyphenyl}-6-5-({2-(methylsulfonyl)ethylamino}methyl)-2-furyl-4-quinazolinamine; GW572016).	Drug metabolism and disposition	2009	62
20952483	18671	Agarwal S	The role of the breast cancer resistance protein (ABCG2) in the distribution of sorafenib to the brain.	The Journal of pharmacology and experimental therapeutics	2011	46
18359942	18787	Shah C	Protection from high fat diet-induced increase in ceramide in mice lacking plasminogen activator inhibitor 1.	The Journal of biological chemistry	2008	50
10359558	19013	Kersten S	Peroxisome proliferator-activated receptor alpha mediates the adaptive response to fasting.	The Journal of clinical investigation	1999	335
10862772	19013	Kersten S	Characterization of the fasting-induced adipose factor FIAF, a novel peroxisome proliferator-activated receptor target gene.	The Journal of biological chemistry	2000	111
12552126	19013	Finck BN	A critical role for PPARalpha-mediated lipotoxicity in the pathogenesis of diabetic cardiomyopathy: modulation by dietary fat content.	Proceedings of the National Academy of Sciences of the United States of America	2003	133
16306350	19013	Tsuchida A	Peroxisome proliferator-activated receptor (PPAR)alpha activation increases adiponectin receptors and reduces obesity-related inflammation in adipose tissue: comparison of activation of PPARalpha, PPARgamma, and their combination.	Diabetes	2005	71
17438130	19013	Shah YM	Peroxisome proliferator-activated receptor alpha regulates a microRNA-mediated signaling cascade responsible for hepatocellular proliferation.	Molecular and cellular biology	2007	74
17550778	19013	Badman MK	Hepatic fibroblast growth factor 21 is regulated by PPARalpha and is a key mediator of hepatic lipid metabolism in ketotic states.	Cell metabolism	2007	360
17652171	19013	Rozema DB	Dynamic PolyConjugates for targeted in vivo delivery of siRNA to hepatocytes.	Proceedings of the National Academy of Sciences of the United States of America	2007	126
18006136	19013	Gonzalez FJ	PPARalpha: mechanism of species differences and hepatocarcinogenesis of peroxisome proliferators.	Toxicology	2008	69
19805517	19013	Sanderson LM	Peroxisome proliferator-activated receptor beta/delta (PPARbeta/delta) but not PPARalpha serves as a plasma free fatty acid sensor in liver.	Molecular and cellular biology	2009	49
20089785	19013	Takikawa M	Dietary anthocyanin-rich bilberry extract ameliorates hyperglycemia and insulin sensitivity via activation of AMP-activated protein kinase in diabetic mice.	The Journal of nutrition	2010	66
20197053	19013	Hondares E	Hepatic FGF21 expression is induced at birth via PPARalpha in response to milk intake and contributes to thermogenic activation of neonatal brown fat.	Cell metabolism	2010	78
21346097	19013	Abdelmegeed MA	PPARalpha expression protects male mice from high fat-induced nonalcoholic fatty liver.	The Journal of nutrition	2011	47
23134073	19013	Woo YC	Fibroblast growth factor 21 as an emerging metabolic regulator: clinical perspectives.	Clinical endocrinology	2013	37
24167256	19013	Wang F	Lipoatrophy and severe metabolic disturbance in mice with fat-specific deletion of PPARÎ³.	Proceedings of the National Academy of Sciences of the United States of America	2013	40
27071062	19013	Stec DE	Bilirubin Binding to PPARÎ± Inhibits Lipid Accumulation.	PloS one	2016	10
12432394	19288	Garlanda C	Non-redundant role of the long pentraxin PTX3 in anti-fungal innate immune response.	Nature	2002	132
14998931	19288	Salustri A	PTX3 plays a key role in the organization of the cumulus oophorus extracellular matrix and in in vivo fertilization.	Development	2004	78
24006456	19288	Abonnenc M	Extracellular matrix secretion by cardiac fibroblasts: role of microRNA-29b and microRNA-30c.	Circulation research	2013	32
24745336	19288	Jaillon S	The humoral pattern recognition molecule PTX3 is a key component of innate immunity against urinary tract infection.	Immunity	2014	27
10469643	19662	Quadro L	Impaired retinal function and vitamin A availability in mice lacking retinol-binding protein.	The EMBO journal	1999	123
16034410	19662	Yang Q	Serum retinol binding protein 4 contributes to insulin resistance in obesity and type 2 diabetes.	Nature	2005	430
16775236	19662	Graham TE	Retinol-binding protein 4 and insulin resistance in lean, obese, and diabetic subjects.	The New England journal of medicine	2006	264
22431523	19662	Norseen J	Retinol-binding protein 4 inhibits insulin signaling in adipocytes by inducing proinflammatory cytokines in macrophages through a c-Jun N-terminal kinase- and toll-like receptor 4-dependent and retinol-independent mechanism.	Molecular and cellular biology	2012	56
23839944	19662	Berry DC	The STRA6 receptor is essential for retinol-binding protein-induced insulin resistance but not for maintaining vitamin A homeostasis in tissues other than the eye.	The Journal of biological chemistry	2013	36
24606904	19662	Moraes-Vieira PM	RBP4 activates antigen-presenting cells, leading to adipose tissue inflammation and systemic insulin resistance.	Cell metabolism	2014	39
11030617	20186	Sinal CJ	Targeted disruption of the nuclear receptor FXR/BAR impairs bile acid and lipid homeostasis.	Cell	2000	326
16446356	20186	Cariou B	The farnesoid X receptor modulates adiposity and peripheral insulin sensitivity in mice.	The Journal of biological chemistry	2006	99
16557297	20186	Ma K	Farnesoid X receptor is essential for normal glucose homeostasis.	The Journal of clinical investigation	2006	159
17183066	20186	Kim I	Spontaneous hepatocarcinogenesis in farnesoid X receptor-null mice.	Carcinogenesis	2007	100
17283114	20186	Yang F	Spontaneous development of liver tumors in the absence of the bile acid receptor farnesoid X receptor.	Cancer research	2007	125
19126757	20186	Lefebvre P	Role of bile acids and bile acid receptors in metabolic regulation.	Physiological reviews	2009	261
21593203	20186	Prawitt J	Farnesoid X receptor deficiency improves glucose homeostasis in mouse models of obesity.	Diabetes	2011	63
25500885	20186	Jiang C	Intestinal farnesoid X receptor signaling promotes nonalcoholic fatty liver disease.	The Journal of clinical investigation	2015	51
12417564	20393	Wulff P	Impaired renal Na(+) retention in the sgk1-knockout mouse.	The Journal of clinical investigation	2002	87
19570885	20393	Vallon V	Expression and phosphorylation of the Na+-Cl- cotransporter NCC in vivo is regulated by dietary salt, potassium, and SGK1.	American journal of physiology. Renal physiology	2009	72
23467085	20393	Wu C	Induction of pathogenic TH17 cells by inducible salt-sensing kinase SGK1.	Nature	2013	174
24705297	20393	Heikamp EB	The AGC kinase SGK1 regulates TH1 and TH2 differentiation downstream of the mTORC2 complex.	Nature immunology	2014	40
11217863	20528	Abel ED	Adipose-selective targeting of the GLUT4 gene impairs insulin action in muscle and liver.	Nature	2001	237
9163428	20778	Kozarsky KF	Overexpression of the HDL receptor SR-BI alters plasma HDL and bile cholesterol levels.	Nature	1997	126
9356497	20778	Rigotti A	A targeted mutation in the murine gene encoding the high density lipoprotein (HDL) receptor scavenger receptor class B type I reveals its key role in HDL metabolism.	Proceedings of the National Academy of Sciences of the United States of America	1997	190
10872459	20778	Krieger M	Charting the fate of the "good cholesterol": identification and characterization of the high-density lipoprotein receptor SR-BI.	Annual review of biochemistry	1999	102
16200214	20778	Zhang Y	Hepatic expression of scavenger receptor class B type I (SR-BI) is a positive regulator of macrophage reverse cholesterol transport in vivo.	The Journal of clinical investigation	2005	83
18064300	20778	Cai L	SR-BI protects against endotoxemia in mice through its roles in glucocorticoid production and hepatic clearance.	The Journal of clinical investigation	2008	50
21953761	20778	Meuleman P	A human monoclonal antibody targeting scavenger receptor class B type I precludes hepatitis C virus infection and viral spread in vitro and in vivo.	Hepatology	2012	41
26965621	20778	Zanoni P	Rare variant in scavenger receptor BI raises HDL cholesterol and increases risk of coronary heart disease.	Science	2016	39
15569937	20807	Miano JM	Restricted inactivation of serum response factor to the cardiovascular system.	Proceedings of the National Academy of Sciences of the United States of America	2004	101
15647354	20807	Li S	Requirement for serum response factor for skeletal muscle growth and maturation revealed by tissue-specific gene deletion in mice.	Proceedings of the National Academy of Sciences of the United States of America	2005	101
16365378	20807	Sun Q	Defining the mammalian CArGome.	Genome research	2006	107
16600861	20807	Etkin A	A role in learning for SRF: deletion in the adult forebrain disrupts LTD and the formation of an immediate memory of a novel context.	Neuron	2006	66
16778073	20807	Pipes GC	The myocardin family of transcriptional coactivators: versatile regulators of cell growth, migration, and myogenesis.	Genes and development	2006	159
16928770	20807	Miano JM	Serum response factor: master regulator of the actin cytoskeleton and contractile apparatus.	American journal of physiology. Cell physiology	2007	159
17215356	20807	Chow N	Serum response factor and myocardin mediate arterial hypercontractility and cerebral blood flow dysregulation in Alzheimer's phenotype.	Proceedings of the National Academy of Sciences of the United States of America	2007	63
18498735	20807	Wickramasinghe SR	Serum response factor mediates NGF-dependent target innervation by embryonic DRG sensory neurons.	Neuron	2008	53
19198601	20807	Medjkane S	Myocardin-related transcription factors and SRF are required for cytoskeletal dynamics and experimental metastasis.	Nature cell biology	2009	121
21393865	20807	Jin W	Increased SRF transcriptional activity in human and mouse skeletal muscle is a signature of insulin resistance.	The Journal of clinical investigation	2011	37
23374345	20807	Gerber A	Blood-borne circadian signal stimulates daily oscillations in actin dynamics and SRF activity.	Cell	2013	25
25868726	20807	Han X	Malat1 regulates serum response factor through miR-133 as a competing endogenous RNA in myogenesis.	FASEB journal 	2015	18
9851930	21898	Poltorak A	Defective LPS signaling in C3H/HeJ and C57BL/10ScCr mice: mutations in Tlr4 gene.	Science	1998	1619
11431739	21898	Uesugi T	Toll-like receptor 4 is involved in the mechanism of early alcohol-induced liver injury in mice.	Hepatology	2001	125
12515817	21898	Boonstra A	Flexibility of mouse classical and plasmacytoid-derived dendritic cells in directing T helper type 1 and 2 cell development: dependency on antigen dose and differential toll-like receptor ligation.	The Journal of experimental medicine	2003	113
14764599	21898	Taylor KR	Hyaluronan fragments stimulate endothelial recognition of injury through TLR4.	The Journal of biological chemistry	2004	148
14970116	21898	Oyama J	Reduced myocardial ischemia-reperfusion injury in toll-like receptor 4-deficient mice.	Circulation	2004	152
15321997	21898	Darveau RP	Porphyromonas gingivalis lipopolysaccharide contains multiple lipid A species that functionally interact with both toll-like receptors 2 and 4.	Infection and immunity	2004	121
15585830	21898	Zhai Y	Cutting edge: TLR4 activation mediates liver ischemia/reperfusion inflammatory response via IFN regulatory factor 3-dependent MyD88-independent pathway.	Journal of immunology	2004	129
15716415	21898	Chakravarty S	Toll-like receptor 4 on nonhematopoietic cells sustains CNS inflammation during endotoxemia, independent of systemic cytokines.	The Journal of neuroscience 	2005	110
17478729	21898	Kim F	Toll-like receptor-4 mediates vascular inflammation and insulin resistance in diet-induced obesity.	Circulation research	2007	161
17637846	21898	Barquero-Calvo E	Brucella abortus uses a stealthy strategy to avoid activation of the innate immune system during the onset of infection.	PloS one	2007	73
17644211	21898	Rivera CA	Toll-like receptor-4 signaling and Kupffer cells play pivotal roles in the pathogenesis of non-alcoholic steatohepatitis.	Journal of hepatology	2007	138
18256356	21898	Zhang B	TLR4 signaling mediates inflammation and tissue injury in nephrotoxicity.	Journal of the American Society of Nephrology 	2008	73
18522803	21898	Shang L	Toll-like receptor signaling in small intestinal epithelium promotes B-cell recruitment and IgA production in lamina propria.	Gastroenterology	2008	53
19461045	21898	Choi SH	Lipoprotein accumulation in macrophages via toll-like receptor-4-dependent fluid phase uptake.	Circulation research	2009	62
19637282	21898	Spruss A	Toll-like receptor 4 is involved in the development of fructose-induced hepatic steatosis in mice.	Hepatology	2009	111
20811584	21898	Hannan TJ	Early severe inflammatory responses to uropathogenic E. coli predispose to chronic and recurrent urinary tract infection.	PLoS pathogens	2010	72
22019135	21898	Christianson CA	Spinal TLR4 mediates the transition to a persistent mechanical hypersensitivity after the resolution of inflammation in serum-transferred arthritis.	Pain	2011	37
23033474	21898	Lin L	Inhibition of LpxC protects mice from resistant Acinetobacter baumannii by modulating inflammation and enhancing phagocytosis.	mBio	2012	37
23091640	21898	Kim KA	High fat diet-induced gut microbiota exacerbates inflammation and obesity in mice via the TLR4 signaling pathway.	PloS one	2012	115
3897439	22041	Doetschman TC	The in vitro development of blastocyst-derived embryonic stem cell lines: formation of visceral yolk sac, blood islands and myocardium.	Journal of embryology and experimental morphology	1985	378
22257828	22041	LÃ¤sser C	Isolation and characterization of RNA-containing exosomes.	Journal of visualized experiments 	2012	80
11687634	22337	Van Cromphaut SJ	Duodenal calcium absorption in vitamin D receptor-knockout mice: functional and molecular aspects.	Proceedings of the National Academy of Sciences of the United States of America	2001	87
12122115	22337	Li YC	1,25-Dihydroxyvitamin D(3) is a negative endocrine regulator of the renin-angiotensin system.	The Journal of clinical investigation	2002	396
15998839	22337	Shimada T	Vitamin D receptor-independent FGF23 actions in regulating phosphate and vitamin D metabolism.	American journal of physiology. Renal physiology	2005	68
17099775	22337	Masuyama R	Vitamin D receptor in chondrocytes promotes osteoclastogenesis and regulates FGF23 production in osteoblasts.	The Journal of clinical investigation	2006	60
20566739	22337	Wu S	Vitamin D receptor negatively regulates bacterial-stimulated NF-kappaB activity in intestine.	The American journal of pathology	2010	57
21190957	22337	Wang Y	Is the vitamin d receptor found in muscle?	Endocrinology	2011	48
22523068	22337	Lieben L	Normocalcemia is maintained in mice under conditions of calcium malabsorption by vitamin D-induced inhibition of bone mineralization.	The Journal of clinical investigation	2012	50
22932118	22337	Lau WL	Vitamin D receptor agonists increase klotho and osteopontin while decreasing aortic calcification in mice with chronic kidney disease fed a high phosphate diet.	Kidney international	2012	38
24284821	22337	Andrukhova O	Vitamin D is a regulator of endothelial nitric oxide synthase and arterial stiffness in mice.	Molecular endocrinology	2014	25
27723756	22337	Wang J	Genome-wide association analysis identifies variation in vitamin D receptor and other host factors influencing the gut microbiota.	Nature genetics	2016	14
11057670	58991	TschÃ¶p M	Ghrelin induces adiposity in rodents.	Nature	2000	552
14585959	58991	Sun Y	Deletion of ghrelin impairs neither growth nor appetite.	Molecular and cellular biology	2003	117
16959833	58991	Holst B	GPR39 signaling is stimulated by zinc ions but not by obestatin.	Endocrinology	2007	61
25685686	58991	Collden G	Neonatal overnutrition causes early alterations in the central response to peripheral ghrelin.	Molecular metabolism	2015	17
16009717	58992	RennÃ© T	Defective thrombus formation in mice lacking coagulation factor XII.	The Journal of experimental medicine	2005	123
20005807	58992	MÃ¼ller F	Platelet polyphosphates are proinflammatory and procoagulant mediators in vivo.	Cell	2009	146
24408325	58992	Matafonov A	Factor XII inhibition reduces thrombus formation in a primate thrombosis model.	Blood	2014	30
24500405	58992	Larsson M	A factor XIIa inhibitory antibody provides thromboprotection in extracorporeal circulation without increasing bleeding risk.	Science translational medicine	2014	34
24855058	58992	Kuijpers MJ	Factor XII regulates the pathological process of thrombus formation on ruptured plaques.	Arteriosclerosis, thrombosis, and vascular biology	2014	21
12874285	64654	Liu S	Regulation of fibroblastic growth factor 23 expression but not degradation by PHEX.	The Journal of biological chemistry	2003	109
14733920	64654	Shimada T	FGF-23 transgenic mice demonstrate hypophosphatemic rickets with reduced expression of sodium phosphate cotransporter type IIa.	Biochemical and biophysical research communications	2004	85
14966565	64654	Shimada T	Targeted ablation of Fgf23 demonstrates an essential physiological role of FGF23 in phosphate and vitamin D metabolism.	The Journal of clinical investigation	2004	289
14988389	64654	Larsson T	Transgenic mice expressing fibroblast growth factor 23 under the control of the alpha1(I) collagen promoter exhibit growth retardation, osteomalacia, and disturbed phosphate homeostasis.	Endocrinology	2004	112
16869716	64654	Burnett SM	Regulation of C-terminal and intact FGF-23 by dietary phosphate in men and women.	Journal of bone and mineral research 	2006	110
17554146	64654	Stubbs JR	Role of hyperphosphatemia and 1,25-dihydroxyvitamin D in vascular calcification and mortality in fibroblastic growth factor 23 null mice.	Journal of the American Society of Nephrology 	2007	68
17855636	64654	Kawata T	Parathyroid hormone regulates fibroblast growth factor-23 in a mouse model of primary hyperparathyroidism.	Journal of the American Society of Nephrology 	2007	60
19419316	64654	Aono Y	Therapeutic effects of anti-FGF23 antibodies in hypophosphatemic rickets/osteomalacia.	Journal of bone and mineral research 	2009	57
21726676	64654	Rhee Y	Parathyroid hormone receptor signaling in osteocytes increases the expression of fibroblast growth factor-23 in vitro and in vivo.	Bone	2011	56
22006328	64654	Farrow EG	Iron deficiency drives an autosomal dominant hypophosphatemic rickets (ADHR) phenotype in fibroblast growth factor-23 (Fgf23) knock-in mice.	Proceedings of the National Academy of Sciences of the United States of America	2011	67
22031097	64654	Stubbs JR	Longitudinal evaluation of FGF23 changes and mineral metabolism abnormalities in a mouse model of chronic kidney disease.	Journal of bone and mineral research 	2012	35
22615579	64654	Wang X	Inactivation of a novel FGF23 regulator, FAM20C, leads to hypophosphatemic rickets in mice.	PLoS genetics	2012	46
23873717	64654	Clinkenbeard EL	Neonatal iron deficiency causes abnormal phosphate metabolism by elevating FGF23 in normal and ADHR mice.	Journal of bone and mineral research 	2014	22
24797667	64654	Andrukhova O	FGF23 regulates renal sodium handling and blood pressure.	EMBO molecular medicine	2014	29
16175608	76282	Li Z	Dietary factors alter hepatic innate immune system in mice with nonalcoholic fatty liver disease.	Hepatology	2005	104
22198329	76282	Sharma V	Induction of oxidative stress, DNA damage and apoptosis in mouse liver after sub-acute oral exposure to zinc oxide nanoparticles.	Mutation research	2012	35
23449255	76282	Bertola A	Mouse model of chronic and binge ethanol feeding (the NIAAA model).	Nature protocols	2013	93
25445398	76282	Idrissova L	TRAIL receptor deletion in mice suppresses the inflammation of nutrient excess.	Journal of hepatology	2015	18
15118091	100102	Maxwell KN	Adenoviral-mediated expression of Pcsk9 in mice results in a low-density lipoprotein receptor knockout phenotype.	Proceedings of the National Academy of Sciences of the United States of America	2004	118
15385538	100102	Park SW	Post-transcriptional regulation of low density lipoprotein receptor protein by proprotein convertase subtilisin/kexin type 9a in mouse liver.	The Journal of biological chemistry	2004	103
15654334	100102	Cohen J	Low LDL cholesterol in individuals of African descent resulting from frequent nonsense mutations in PCSK9.	Nature genetics	2005	253
15805190	100102	Rashid S	Decreased plasma cholesterol and hypersensitivity to statins in mice lacking Pcsk9.	Proceedings of the National Academy of Sciences of the United States of America	2005	151
17080197	100102	Lagace TA	Secreted PCSK9 decreases the number of LDL receptors in hepatocytes and in livers of parabiotic mice.	The Journal of clinical investigation	2006	123
18039658	100102	Poirier S	The proprotein convertase PCSK9 induces the degradation of low density lipoprotein receptor (LDLR) and its closest family members VLDLR and ApoER2.	The Journal of biological chemistry	2008	73
18354138	100102	Grefhorst A	Plasma PCSK9 preferentially reduces liver LDL receptors in mice.	Journal of lipid research	2008	56
18666258	100102	Zaid A	Proprotein convertase subtilisin/kexin type 9 (PCSK9): hepatocyte-specific low-density lipoprotein receptor degradation and critical role in mouse liver regeneration.	Hepatology	2008	66
18695239	100102	Frank-Kamenetsky M	Therapeutic RNAi targeting PCSK9 acutely lowers plasma cholesterol in rodents and LDL cholesterol in nonhuman primates.	Proceedings of the National Academy of Sciences of the United States of America	2008	143
19443683	100102	Chan JC	A proprotein convertase subtilisin/kexin type 9 neutralizing antibody reduces serum cholesterol in mice and nonhuman primates.	Proceedings of the National Academy of Sciences of the United States of America	2009	80
19635789	100102	Poirier S	Dissection of the endogenous cellular pathways of PCSK9-induced low density lipoprotein receptor degradation: evidence for an intracellular route.	The Journal of biological chemistry	2009	46
22261195	100102	Denis M	Gene inactivation of proprotein convertase subtilisin/kexin type 9 reduces atherosclerosis in mice.	Circulation	2012	34
22294692	100102	Chaparro-Riggers J	Increasing serum half-life and extending cholesterol lowering in vivo by engineering antibody with pH-sensitive binding to PCSK9.	The Journal of biological chemistry	2012	38
23690465	100102	Tavori H	Serum proprotein convertase subtilisin/kexin type 9 and cell surface low-density lipoprotein receptor: evidence for a reciprocal regulation.	Circulation	2013	39
24506872	100102	Gustafsen C	The hypercholesterolemia-risk gene SORT1 facilitates PCSK9 secretion.	Cell metabolism	2014	28
24603306	100102	Miranda MX	The Sirt1 activator SRT3025 provides atheroprotection in Apoe-/- mice by reducing hepatic Pcsk9 secretion and enhancing Ldlr expression.	European heart journal	2015	18
24916110	100102	Ding Q	Permanent alteration of PCSK9 with in vivo CRISPR-Cas9 genome editing.	Circulation research	2014	44
25341796	100102	Roche-Molina M	Induction of sustained hypercholesterolemia by single adeno-associated virus-mediated gene transfer of mutant hPCSK9.	Arteriosclerosis, thrombosis, and vascular biology	2015	18
25830891	100102	Ran FA	In vivo genome editing using Staphylococcus aureus Cas9.	Nature	2015	251
15611994	104245	Zeilhofer HU	Glycinergic neurons expressing enhanced green fluorescent protein in bacterial artificial chromosome transgenic mice.	The Journal of comparative neurology	2005	87
7566151	109648	Stephens TW	The role of neuropeptide Y in the antiobesity action of the obese gene product.	Nature	1995	135
8603777	109648	Schwartz MW	Specificity of leptin action on elevated blood glucose levels and hypothalamic neuropeptide Y gene expression in ob/ob mice.	Diabetes	1996	118
16099943	109648	Bewick GA	Post-embryonic ablation of AgRP neurons in mice leads to a lean, hypophagic phenotype.	FASEB journal 	2005	72
18800067	109648	Wittmann W	Prodynorphin-derived peptides are critical modulators of anxiety and regulate neurochemistry and corticosterone.	Neuropsychopharmacology 	2009	60
25865495	232333	Carvill GL	Mutations in the GABA Transporter SLC6A1 Cause Epilepsy with Myoclonic-Atonic Seizures.	American journal of human genetics	2015	16
15538359	238055	Soutschek J	Therapeutic silencing of an endogenous gene by systemic administration of modified siRNAs.	Nature	2004	444
20615897	238055	Straarup EM	Short locked nucleic acid antisense oligonucleotides potently reduce apolipoprotein B mRNA and serum cholesterol in mice and non-human primates.	Nucleic acids research	2010	51
